DRUG SUSCEPTIBILITY PATTERN AND ASSOCIATED FACTORS AMONG UNDER FIVE CHILDREN IN DIRE DAWA, EASTERN ETHIOPIA MSc Research Thesis Mohammed Mekonnen (BSc) April 2015 Haramaya University, Haramaya Drug Susceptibility Pattern and Associated Factors among Under Five Children in Dire Dawa, Eastern Ethiopia A thesis submitted to College of Health and Medical Sciences, School of Graduate Studies, HARAMAYA UNIVERSITY In partial fulfillment of the requirements for the degree of MASTER OF SCIENCE IN MEDICAL MICROBIOLOGY Mohammed Mekonnen Major Advisor: Senthilkumar Balakrishnan (MSc, PhD) Co-Advisor: Biftu Geda (MScN, PhD candidate) April, 2015 Haramaya University, Haramaya HARAMAYA UNIVERSITY SCHOOL OF GRADUATE STUDIES APPROVAL SHET I hereby certify that I have read and evaluated this Thesis entitled “Bacterial Diarrhoea, Their Antibiotic Susceptibility Pattern And Associated Risk Factors Among Under Five Children In Dil-Chora Referral Hospital, Dire Dawa, Ethiopia” prepared under my guidance by Mohammed Mekonnen. I recommend that it be submitted as fulfilling the thesis requirements. ____________________ Major Advisor ____________________ Co-Advisor Advisor _____________ Signature ______________ Signature _________ Date __________ Date As a member of the Board of Examiners of the MSc Thesis Open Defense Examination, I certify that I have read and evaluated the Thesis prepared by Mohammed Mekonnen and examined the candidate. I recommend that the thesis be accepted as fulfilling the Thesis requirements for the degree of Masters of Science in Medical Microbiology. ______________________ Chairperson ___________________ Signature ______________________ ___________________ Internal Examiner Signature ______________________ ___________________ External Examiner Signature ___________ Date ___________ Date ___________ Date Final approval and acceptance of the Thesis is contingent upon the submission of its final copy to the Council of Graduate Studies (CGS) through the candidate’s department or school graduate committee (DGC or SGC) STATEMENT OF THE AUTHOR By my signature below, I, Mohammed Mekonnen, declare and affirm that this thesis is my own work. I have followed all ethical and technical principles of scholarship in the preparation, data collection, data analysis and compilation of this thesis. Any scholarly matter that is included in the thesis has been given recognition through citation. This thesis is submitted in partial fulfillment of the requirements for the degree of maters of sciences in Medical Microbiology at the Haramaya University. The thesis is deposited in the Haramaya University Library and is made available to borrowers under the rules of the Library. I solemnly declare that this thesis has not been submitted any other institution anywhere for the award of any academic degree, diploma or certificate. Brief questions from thesis may be made without special permission provided that accurate and complete acknowledgement of the source is made. Requests for permission for extended quotations from or reproduction of this thesis in whole or part may be granted by the head of the school or department when in his or judgment the proposed use of the material is in the interest of scholarship. In all other instances, however, permission must be obtained from the author of the thesis. Name: _________________________ Signature________________ Date: ______________________________ School/Department: _____________________________ iii BIOGRAPHICAL SKETCH I was born in 1983 GC in South Wollo, Combolcha Town. I completed my Elementary and junior education in Combolcha Elementary School, Grade 9 and 10 in Nifas Silk High School and Grade 11 in Abiot Kirse High School, both in Addis Ababa, and Grade 12 in Fasiledes High School in Gondar. Then I have graduated from Jimma University with Bachelors of Science in Medical Laboratory Technology in 2006. After graduation, I have been working at different health facilities such as Mizan Teferi Health Center for one year, Dire Dawa Bilal Hospital for one and half year and Dire Dawa rural health center for two years. However, since 2011 I am working at Dire Dawa Dil Chora Referral Hospital as Senior Laboratory Technologist. iv ACKNOWLEDGEMENTS First and for most, I Would like to thank School of Graduate Studies, Haramaya University in laying fertile ground in preparation of this thesis. My acknowledgement goes to my advisors Dr. SenthilKumar Balakrishnan and Mr. Biftu Geda for their valuable guidance, suggestions and support since the development of the proposal until the preparation of this thesis. .My heartfelt gratitude also extends to all the Institutional Health Research Ethics Review Committee for their constructive comments given to finalize the development of this thesis. I am also grateful to all my research team who dedicated their full time and effort during data collection. I would like to thank Dire Dawa Administrative Health Bureau and Dil-Chora Referral Hospital for their cooperation in undertaking this research and also to all participated under five children together with their families for their participation and support in providing the required information for this research. I would like to thank all staff member of Dil-Chora Hospital Laboratory for their precious support in every circumstance. vi ACRONYMS AND ABBREVIATIONS CSA- Central Statistics Agency DDA- Dire Dawa Administration DTC- Drug Therapeutic Committee EBR- Ethiopian Birr EDHS- Ethiopian Disease and Health Survey EIEC- Enter Invasive Escherichia coli EPEC- Enteropathogenic Escherichia coli ETEC- Enterotoxigenic Escherichia coli MAC- MacConkey MIU- Motility Indole Urea ORS- Oral Rehydration Salts SS- Salmonella and Shigella UNICEF- United Nations International Children Emergency Fund WHO- World Health Organization MDR – Multi- Drug Resistance vii TABLE OF CONTENTS STATEMENT OF THE AUTHOR iii BIOGRAPHICAL SKETCH iv ACKNOWLEDGEMENTS vi ACRONYMS AND ABBREVIATIONS vii TABLE OF CONTENTS viii ABSTRACT xii 1. INTRODUCTION 1 1.1 Background 1 1.2 Statement of the Problem 3 1.3 Significance of the Study 5 1.4. Objectives 5 1.4.1 General Objective: 5 1.4.2 Specific Objectives: 5 6 2. LITERATURE REVIEW 2.1. Review of Studies on Prevalence of Common Bacterial Cause of Diarrhoea 6 2.3. Drug Resistance Patterns Of Common Bacterial cause of diarrhoea 7 2.4. Associated Risk Factors of Bacterial Cause of Diarrhoea 9 3. MATERIALS AND METHODS 11 3.1. Study Area 11 3.2. Study Period 11 3.3. Study Design 11 3.4. Population 12 3.4.1. Source Population 12 3.4.2. Study population 12 3.4.3. Inclusion and Exclusion Criteria 12 3.5. Sampling 12 3.5.1. Sample Size Determination 12 3.5.2. Sampling Procedure 13 3.6. Data Collection 13 3.7. Screening and Identification of Bacterial Agents Causing Diarrhoea 13 3.7.1. Stool Sample Collection 13 3.7.2. Inoculation and Incubation 14 3.7.3. Isolation and Identification 14 viii 3.7.4. Antibiotic Sensitivity Test 14 3.8. Study Variables 15 3.8.1. Dependent/ Outcome variable 15 3.8.2. Independent/ Explanatory Variables 15 3.9. Operational Definition of Variables 15 3.10. Data Quality Control 16 3.11. Data Analysis 17 3.12. Data Dissemination 17 4. RESULTS 18 4.1. Prevalence of Enteric Bacteria 19 4.2. Antibiotic Susceptibility Pattern of Bacterial Isolate 22 4.3. Possible Associated Factors of Bacterial Diarrhoea 25 5. DISCUSION 27 6. STRENGTH AND LIMITATION OF THE STUDY 32 6.1. STRENGTH 32 6.2. LIMITATION OF THE STUDY 32 7. CONCLUSION AND RECOMMNDATION 33 7.1. Conclusion 33 8. REFERENCE 35 9. ANNEXURES 39 Annexure- 1: Participant Information Sheet and Informed Consent Form for Parents or Guardians of Under Five Children Involved In the Study 39 Annexure-2: በጥናቱ ላይ ለሚሳተፉ የህፃኑ እናት ወይም ጠባቂ 43 Annexure-3: Odeefannon hirmattotaa Qo’annoo waa’ee jermilee garaa kaasaa fidaniifi qorichaa waliin walbaruu isaanii daa’immani ilaala 47 Annexure-4: Waxaan akhriyey warqada warbixinta Xaaladaha cayayaanka ili ma argtayda iyo kudul noolayaasha ku keena shuubanka iyo ka hortaga u nuglaanshahooda caruurta 5 sano ka yare e dhakhtarka 51 Annexure- 5:- Informed Consent Form for Dil Chora Hospital Chief Executive Officer 55 Annexure -6: Laboratory Data 57 Annexure-7: Curriculum Vitae 59 ix LIST OF TABLES PAGE Table-1:- Distribution of E. coli, Shigella and Salmonella sp among under five children with diarrhea at Dil-Chora Referral Hospital from February to March 2015, Dire Dawa, Eastern Ethiopia. 19 Table-2:- Distribution of E. coli, Shigella and Salmonella sp with clinical data among under five children with diarrhea at Dil-Chora Referral Hospital from February to March 2015, Dire Dawa, Eastern Ethiopia. 20 Table-3:- Distribution of E. coli, Shigella and Salmonella sp with environmental characteristics among under five children with diarrhea at Dil-Chora Referral Hospital from February to March 2015, Dire Dawa, Eastern Ethiopia. 22 Table- 4: Antimicrobial sensitivity and resistant pattern of bacteria isolate among children under age of five years at Dil-Chora Referral Hospital from February to March 2015, Dire Dawa, Eastern Ethiopia. 23 Table-5: Antibiogram of bacterial pathogens isolated from under-five children with diarrhea at Dil-Chora Referral Hospital from February to March 2015, Dire Dawa, Eastern Ethiopia. 24 Table- 6: Multivariable analysis of risk factors for bacterial diarrhoea among under 5 children at Dil-Chora Referral Hospital from February to April 2015, Dire Dawa. x 26 LIST OF FIGURE PAGE Figure-1: Conceptual Framework of Associated Factors for enteric bacterial pathogens and Drug Resistance pattern 10 Figure- 2: Age and Sex Distribution of study participants xi 18 ABSTRACT Globally, diarrhoea remains the second leading cause of death among under five children. In developing countries including Ethiopia reports indicated that 50-60% of diarrhoea is caused by bacteria of which Enteropathogenic Escherichia coli (EPEC) accounts 25%, Enterotoxigenic E.coli (ETEC) accounts 10-20%, Campylobacter jejuni 10-18%, Shigella species 5-15%, and Salmonella species accounts 5%. In addition, the emergence of multidrug resistance enteric bacteria is becoming a major medical and public health problem. Therefore, this study aimed to identify the bacterial cause of diarrhoea, antibiotic susceptibility pattern and associated factors among under five children at Dil-Chora Hospital from Feb 20 to March 30/2015. A hospital based cross-sectional study was conducted and a total of 196 under-five children with diarrhea were included consecutively. Demographic, environmental and clinical data were collected using questionnaire. Stool samples were collected and inoculated on Selenite-F broth, SS agar, MacConky and DCA. Antimicrobial susceptibility test was performed following standard bacteriological techniques. Descriptive statistics was used to present the findings. Binary logistic regression was used to measure the association between dependent and independent variables and significant variables were further adjusted using multivariate analysis. A p-value <0.05 was considered as level of significance. The overall prevalence of enteric bacteria in this study was 21.9%. E. coli was the dominant bacteria isolated (12.8%), followed by Shigella (5.6%) and Salmonella sp (3.6%). None of the bacteria isolates showed resistance to Ceftriaxone, while 100% resistance to Amoxicillin was observed by Shigella sp, 85.7% by Salmonella and 56% by E. coli. Resistance for Ampicillin was 90.9%, 71.4% and 52% by Shigella, Salmonella and E. coli isolates. All Shigella isolates were found to be multi drug resistant. Hand washing after toilet use showed statistical significant association with culture positivity of Salmonella and Shigella sp. Therefore, children’s family should be educated to wash their hands after toilet as this is cost-effective public health interventions. KEYWORDS: Under-Five Diarrhoea, Enteric Bacteria, Drug Resistant, Risk Factors. xii 13 1. INTRODUCTION 1.1 Background Enteric bacteria are microorganisms which have the potential of causing disease in the intestinal track (WHO, 2013). These organisms are abundant and ubiquitous in nature: they exist in soil, water, air, and food; they can evolve quickly by exchanging genetic materials to acquire properties that help them to create new strain and to colonize new host (El-Astal, 2005). When ingested with contaminated water and food, they invade and colonize the host tissue, causing diarrhoea (WHO, 2007). The common bacterial agent of childhood diarrhoea includes diarrhoeagenic E.coli, Salmonella and Shigella sp, Vibrio cholerae, Campylobacter sp (Merson et al., 2005). Majority of children infected with these enteropathogens often experience symptoms of watery and loose stools, fever, abdominal cramps, nausea, vomiting, loss of appetite, weight loss, and dehydration due to loss of fluids and electrolyte is the most common complication of infectious diarrhoea (UNICEF/WHO, 2009). Globally, diarrhoea remains the second leading cause of death among under five children, and is responsible for killing around 760,000 children every year (WHO, 2013; Christa et al., 2013). About 72% of deaths associated with diarrhoea happen in the first 2 years of life, suggesting that an increased emphasis on prevention and treatment in neonates and children younger than 2 years is crucial (Christa et al., 2013). It was indicated that, nearly three quarters of child deaths in the world occurs in 15 countries and Ethiopia was at the fifth rank with estimated 73,700 total number of annual child deaths due to diarrhoea (WHO, 2007). Diarrhoea due to microbial infection is widespread throughout developing countries (WHO, 2013). It is reported that 50-60% diarrhoeal cases in developing countries including Ethiopia are of bacterial origin: Enteropathogenic E.coli (EPEC) accounts 25%, Enterotoxigenic E.coli (ETEC) accounts 10-20%, Campylobacter jejuni 10-18%, Shigella sp 5-15%, and Salmonella sp accounts 5% (Naghipour et al, 2008; Elliott, 2007). All these pathogens share a similar feco-oral route of transmission. Fecal contamination of food and drinking water is considered as the common source of enteric pathogens (UNICEF/WHO, 2009). 1 It is recommended that antibiotics should be given in cases of cholera, dysentery/shigellosis and campylobacteriosis (Dutta et al., 2003). Doxycycline/ Tetracycline, both are used in the treatment of Cholera. Coterimoxazole suspension (240mg/5ml) is commonly prescribed drugs for shigella dysentery (Ravi et al., 2004). Although the severity of symptoms caused by these enteropathogens can be reduced with antibiotics, in this era of the 21th century, majority are becoming resistant to the latest antibiotics (Reda et al., 2011). Stool culture and microscopy are very important in identifying enteropathogens in the management of diarrhoea, particularly during outbreak investigations (WHO, 2005). Guidelines from physician groups and public health agencies also promote the use of diagnostic stool cultures when prescribing antibiotics for childhood diarrhea (Guerrant et al., 2001). It is known that antimicrobial treatment that is tested and properly selected using stool culture has the advantages of reducing the emergence of resistant strain as well as minimizing the risk of over-dose (El-Astal, 2005). Hence, one way to control and lessen the burden caused by infectious diarrhoea can be achieved through the use of diagnostic stool culture for identifying common enteric pathogens and the development of antibiotic profile for early and better treatment. Assessing associated factors of diarrhoea is important to know the source of the outbreak and thereby limiting the spread of these enteropathogens (UNICEF/WHO, 2009). In addition, Programme planning and implementation needs to be adjusted to the specific requirements and needs of a local setting (IOM, 2009). Thus, understanding nature of the problem, its magnitude and distribution among children at the study area is the key in designing strategies in the prevention and control of childhood diarrhoea. 2 1.2 Statement of the Problem Childhood diarrhoea, caused by a host of bacterial, viral and parasitic pathogens, is the second leading cause of child mortality and morbidity in the world (UNICEF, 2012). Despite major advance in prevention and treatment, each year nearly 1.7 billion cases of diarrhoea occurred (WHO, 2013). Childhood diarrhoea accounted for 700,000 deaths among under five children worldwide and the highest mortality rate occurred in Sub-Saharan Africa and Southeast Asia (Bhutta et al., 2013). This is because children living in poor or remote communities are most at risk and evidence shows children are dying from this preventable disease because effective interventions are not provided equitably across all communities (WHO/UNICEF, 2013). In addition to the high burden of mortality, the effect diarrhoea in children are many, including concomitant infections, recurrent diarrhoea, failure to thrive as well as school performance (frequent absenteeism from school), increased cost for medical expenses, and other socio and emotional problems (Alvin et al.,2013). In Ethiopia, diarrhea is the second leading cause of morbidity and mortality among under five children (Global Burden of Disease, 2010). In addition, the emergence of antibiotic resistant enteric bacterial strain is becoming major medical and public health problem (Asrat, 2008). According to the report of study conducted in Harar, Shigella sp showed high resistance against Amoxicillin (100), Ampicillin (100%) and Tetracycline (70.6%) (Reda et al., 2011). Similar study reported that the most strains of Shigella sp in Ethiopia was resistant to Erythromycin (100.0%), Tetracycline (97.3%), Cephalothin (86.7%), Ampicillin (78.7%), Chloramphenicol (74.7%) and Sulfonamide (54.7%) (Asrat, 2008). This is because antibiotics are frequently used inappropriately and this leads to adverse outcomes, increased costs, and drug resistance due to very fast arising and spread of mutant strains of enteric bacteria that are insusceptible to treatment (El-Astal, 2005). The increasing antibiotic resistance because of overuse and misuse of antibiotics for the treatment of diarrheal diseases in developing countries is becoming an alarming issue (Reda et al., 2011). 3 Despite the current effort in the prevention and control of childhood diarrhoea, data showed that the prevalence of bloody diarrhoea increased in Dire Dawa (EDHS, 2011). Although early diagnosis followed by immediate and adequate therapy is essential to treat diarrhoea, in Dire Dawa and most regions of Ethiopia, antibiotic treatment is largely empiric. There is also information gap identified in the study area: information about common bacterial causes of diarrhoea, their antibiotic profile and associated factors not available. The high prevalence of infectious diarrhoea and the emergence of resistant bacteria to common antibiotics though necessitate identifying common enteric bacteria and testing their antibiotics susceptibility, no previous study conducted in Dire Dawa. However, few studies approach the problem only by focusing on the prevalence and determinants of diarrhoea. Thus, in order to effectively prevent diarrhea, it is imperative that the common etiological agents, their antibiotic susceptibility pattern and associated factors should be identified first (Ansari et al, 2012). Therefore, this study aimed to identify the bacterial cause of diarrhoea, antibiotic susceptibility pattern and associated factors among children under age of five years at DilChora Referral Hospital. 4 1.3 Significance of the Study The finding of this study expected to provide important information about common bacterial cause of childhood diarrhoea, their antibiotic sensitivity and resistance pattern and local risk factors. The data obtained from drug sensitivity test will help and guide other health care workers to select the best antibiotics for diarrhoea treatment, helps to minimize inappropriate use of antibiotics so that the emergence of multi-drug resistant strain of enteric bacteria will be reduced. In addition it will also guide Drug Therapeutic Committee (DTC) in the distribution of essential antibiotics among the health facilities. Identification of pathogens and risk factors, and then recommendations of simple, immediate, and effective risk-reduction measures will help local health care services to reduce morbidity and mortality due to diarrhea among children <5 years in the area. 1.4. Objectives 1.4.1 General Objective: The objective of this study was to identify bacterial cause of diarrhoea, drug susceptibility pattern and associated factors among under five children in Dire Dawa from February 20March 30/2015. 1.4.2 Specific Objectives: 1. To identify common bacterial cause of diarrhea among under five children. 2. To determine the antibiotic sensitivity and resistance pattern of the bacterial isolate. 3. To assess associated factors of bacterial cause of diarrhoea. 5 2. LITERATURE REVIEW 2.1. Review of Studies on Prevalence of Common Bacterial Cause of Diarrhoea A hospital based cross sectional study was conducted on prevalence and etiology of diarrhoea among under five children in Tikrit, Iraq (2004 to 2005). It was reported that the prevalence was 32.4% and the most commonly isolated microbial agent was EPEC (25.9%), followed by C. difficile (21.0%). Bacterial infectious agents were the most common cause of infectious diarrhoea accounting 67.9% isolates. Single infectious agents caused 63.1% of the cases, while mixed infections were detected in 16.7% (Alrifai et al., 2009). Another study conducted on bacterial etiology of acute diarrhoea among children under age of five in Nepal (2011) indicated that the prevalence of Shigella sp was 4.6% followed by E. coli 2.3% and Salmonella sp 1.9%. In this study Shigella sp was the only pathogen significantly associated with diarrhea (Ansari .et al., 2012). Similar study done by Jeevan et al in Nepal (2009) indicates that overall prevalence of pathogenic bacteria was 57/285 (20%). Among the pathogenic bacteria isolated, the predominant bacteria were Shigella sp(36.8%), Vibrio sp (26.3%), E.coli (22.8%) and Salmonella sp (14.03%) respectively. It was concluded that the infection was peak in children under 2 years of age and was highest in rainy season (Jeevan et al., 2009). Different Studies conducted in developing countries indicated that 50-60% diarrhoeal cases are of bacterial origin of which Enteropathogenic E.coli (EPEC) accounts 25%, C. jejuni 1018%, Salmonella and Shigella sp accounts 5% each (Elliott, 2007; Naghipour, 2008). In Botswana (1998), 21% Shigella and 3% Salmonella sp was isolated from children under 5 years (Urio et al., 2001). Another study conducted in Nepal (2004) reported that the incidence of Vibrio cholerae O1 to be 42.2% (Roshani, 2007) and 0.07% in Kenya (2007 to 2008) (Willie, 2012) while Enteropathogenic E. coli (25.9%) and Cl.difficile (21.0%) isolated in Tikrit, Iraq (2004 to 2005) (Alrifai, 2009). A study in Kenya conducted from 2007 to 2008 stated that 17.7% enteropathogens were identified, among these pathogenic E. coli accounts 11.2%, Salmonella 3.5%, Shigella 2% and V. cholerae O1 0.7% (Willie et al 2012). 6 A hospital based cross-sectional study conducted at Hawassa in 2011 indicated that 35(22.2%) bacterial pathogens were isolated. The isolated bacteria were Campylobacter sp 20 (12.7%), Shigella sp 11 (7.0%), and Salmonella sp 4 (2.5%) (Mulatu et al., 2014). 2.3. Drug Resistance Patterns of Common Bacterial Cause of Diarrhoea In Nepal (2004), Tetracycline was found to be 100% effective antibiotics followed by Norfloxacin and Ciprofloxacin to V. cholerae O1 (Roshani, 2007). Whereas, in 2011 in Nepal, Chloramphenicol and Tetracycline showed efficacy in 90.0% isolates of Salmonella sp, Gentamicin showed efficacy in 91.7% isolates of Shigella sp and Chloramphenicol showed 100% efficacy against E.coli. Similarly 70.0% isolates of Salmonella sp were resistant to ampicillin in vitro. MDR was highest 70.0% in Salmonella sp (Ansari .et al., 2012). In Botswana (1998), antibiograms of the predominant isolates showed that most Shigella sp was resistant to Ampicillin but susceptible to Chloramphenicol, and Gentamicin. Salmonella sp were susceptible to Chloramphenicol, Collistin-Sulphate, Gentamicin, Cotrimoxazole, and Ampicillin (Urio et al., 2001). In Kenya (2008), the highest level of antimicrobial resistance among E.coli isolates were observed in Ampicillin and Trimethoprim/Sulphamethoxazole each at 95% followed by Tetracycline at 81% (Willie et al 2012). In other similar study conducted in Madagascar (2008 to 2009) found that many E. coli and Shigella isolates (around 80%) but fewer Salmonella isolates were resistant to Ampicillin and Trimethoprim/Sulfamethoxazole. A small proportion of strains of each species were resistant to Ciprofloxacin and only 3% of E. coli strains presented a resistance to third generation Cephalosporins due to the production of extended-spectrum beta-lactamases. The resistance of Campylobacter sp to Ampicillin was the most prevalent, whereas less than 5% of isolates were resistant to each of the other antibiotics. The highest prevalence of antimicrobial resistance was to Ampicillin and Trimethoprim/Sulfamethoxazole (Randrianirina et al. 2014). According to Asrat (2008), the most strains of Shigella sp in Ethiopia was resistant to Erythromycin (100.0%), Tetracycline (97.3%), Cephalothin (86.7%), Ampicillin (78.7%), Chloramphenicol (74.7%) and Sulfonamide (54.7%) (Asrat, 2008). Moreover, Yismaw et al 7 (2006) in Gondar also revealed that there was high resistance of Shigella sp against Ampicillin (79.9%), Tetracycline (86 %) and Cotrimoxazole (73.4%) (Yismaw et al., 2006). In addition, a similar study done in Harar (2010) on drug susceptibility of Shigella sp showed high resistance against Amoxicillin (100), Ampicillin (100%) and Tetracycline (70.6%) (Reda et al., 2011), whereas resistance for Salmonella sp against Ampicillin (81.2%), Cephalothin (86.4%), Chloramphenicol (83.7%), Erythromycin (100.0%), Gentamicin (75.6%), Sulfonamide (81.1%), Tetracycline (94.5%) and Trimethoprim-Sulfamethoxazole (75.7%) was reported by Asrat (2008) done in Ethiopia (Asrat, 2008). Likewise, the resistance to Amoxicillin (100%), Ampicillin (100%), Tetracycline (71.4%) and Chloramphenicol (62.3%) of Salmonellas spp was reported by Reda et al in 2010, Harar (Reda et al., 2011). A similar study in Hawassa (2011) indicated that the majority of the bacterial isolates such as Campylobacter, Shigella and Salmonella spp were sensitive to Chloramphenicol, Ciprofloxacin, Nalidixic acid and Cotrimoxazole and high rate of drug resistance was observed against Erythromycin and Amoxicillin (Mulatu et al., 2014). A health institution based cross sectional study was conducted on the prevalence of bacterial and parasitic cause of diarrhoea in 2012, Jimma and 6 (2.3%) and 16 (6.2%) samples were positive for Shigella and Salmonella spp respectively. Shigella sp showed hundred percent resistances to Ampicillin, Amoxicillin, and Cotrimoxazole. All Salmonella isolates were resistant against Amoxicillin. All Shigella and Salmonella sp were susceptible to Ceftriaxone, Ciprofloxacin and Gentamycin (Beyene and Tasew, 2014). Moreover, a study on antimicrobial susceptibility of Shigella sp in Hawassa (2000), indicated the presence of high resistance against Gentamicin (96%), Nalidixic acid (90%), Ampicillin (93%), Erythromycin (90%) and Tetracycline (90%). MDR Shigella isolates which showed resistance to six antibiotics (Ampicillin, Erythromycin, Cephalothin, Chloramphenicol, Tetracycline and Trimethoprim-sulfamethoxazole) has also been observed (Roma et al., 2000). Another study conducted in Jimma (2004) on drug susceptibility profile of Campylobacter sp reported that the isolates showed 50% and 60% resistance rate to Ampicillin and Trimethoprim-sulfamethoxazole respectively (Beyene and Haile-Amlak, 2004). 8 2.4. Associated Factors of Bacterial Cause of Diarrhoea It is widely recognized that exposure to diarrhoea pathogens in developing countries is associated with the age of the child, quality and quantity of water, availability of toilet facilities, housing conditions, household economic status, place of residence, feeding practices, and the general sanitary conditions (personal or domestic hygiene) in the vicinity of the house (Andualem, 2010; WHO/UNICEF, 2009; Wondwossen, 2008). A study conducted in Nepal (2011) showed that bacterial infection was found to be of highest (78.3%) in the age group between 6-24 months. Occurrence of bacterial pathogens in children below 2 years of age was statistically significant than in those above 2 years of age. Boys had higher diarrheal cases (64.2%) than girls (35.8%). Bacterial pathogen infected cases were 47.8% among male while it was 52.2% among female (Ansari et al., 2012). A similar study conducted by Alrifai et al in Tikrit, Iraq (2004 to 2005) reported that the age group > 6–12 months was the age group most affected by nosocomial diarrhoea (30.9% of isolates), followed by age group 1–6 months (25.9 % of isolates) (Alrifai et al., 2009). In Ethiopia, many factors have been indicated to contribute for childhood diarrhoea, such as history of maternal diarrhea illness, mode of feeding practice and nutritional status in Shebedino District in 2013 (Alemu et al., 2014); latrine ownership, availability of home based water treatment and source of water in Derash District in 2012 (Wanzahun, 2013); while in 2013 in North Shoa Zone occupation of mothers (private workers), maternal history of recent diarrhoea, living with cattle in one house, address (rural), feeding of gruel, feeding of adult’s food for children, method of dipping to take water from water containers and water storage container without cover had significant association with diarrheal diseases (Mamo and Hailu, 2014). In 2010 Diarrhoea prevalence is highest among those children residing in households that drink from unprotected wells (18%), and those residing in rural areas (14%) (EDHS, 2011). 9 Conceptual Framework Socio-demographic Age and Sex of child Residence of the child Previous History of Diarrhoea And previous treatment OUTCOME Environmental Factors ⁞ Bacterial cause of diarrhoea and Drug Resistance water source Refuse Disposal Sanitation Behavioral Factors Hand washing behavior of child’s parents Feeding practices Figure-1: Conceptual Framework of Associated Factors for Bacterial Cause of Diarrhoea and Drug Resistance pattern 10 3. MATERIALS AND METHODS 3.1. Study Area The study was conducted in Dil-Chora Referral Hospital, Dire Dawa Administration. Dire Dawa is one of the two chartered cities in Ethiopia. It is located in the eastern part of Ethiopia which is 550 Km away from Addis Ababa, and it lies with a latitude and longitude of 9o36’N 41o52’E. The administration has nine urban and thirty eight rural kebeles. Based on the 2007 Census conducted by the Central Statistical Agency of Ethiopia (CSA), Dire Dawa has a total population of 342,827. Of whom, 171,930 were men and 170,897 women; 232,854 (69.92%) of the population are considered urban inhabitants, with an estimated area of 1,231.20 square kilometers (CSA, 2007). Currently the Administration has six hospitals (2 governmental, 3 private and 1 EthioDjibouti hospitals), 16 health centers, 34 health posts, and 32 private clinics. As referral hospital, Dil-Chora has no demarcated catchment area and it gives referral service for all eastern Ethiopian populations. The hospital has an emergency, central and microbiology referral laboratory staffed with 10 laboratory technologists and 7 laboratory technicians. Central laboratory and Microbiology department gives service to the hospital and the referring health facility found in and around Dire Dawa. The pediatric unit, consisting of two pediatrician, one clinician and 10 clinical nurses, gives outpatient and inpatient service as well as oral rehydration therapy (ORT) for severely dehydrated patients. According to 2014 estimates of CSA, the total number of under five child population is 12.14% and the prevalence of diarrhoea among children under the age of five years is 9.4% with 3 diarrhoeal episodes (CSA, 2014 Unpublished). 3.2. Study Period The study was conducted in Dire Dawa, Dil-Chora Referral Hospital pediatric unit from February 20 to March 30, 2015. 3.3. Study Design A hospital based cross-sectional study was conducted using pre-tested and structured questionnaire. 11 3.4. Population 3.4.1. Source Population All children under the age of five years visiting Dil-Chora Referral Hospital 3.4.2. Study population Children under age of five years who have diarrhea and available during data collection period 3.4.3. Inclusion and Exclusion Criteria Children less than five years of age with diarrhoea and who had not taken any antibiotic in the past five days for the disease was included in the study. Thus either medical records or parents of the child were used to check whether the child took antibiotic or not. Those children who did not fulfill the above criteria and whose parents not volunteer to participate in the study were excluded. 3.5. Sampling 3.5.1. Sample Size Determination The sample size for this study was calculated using the formula for estimation of single n= z2 x p (1-p)/ r2 proportion (Kelsey et al., 1996) Where: P is the prevalence of campylobacter species (12.7%) among under five children taken from previous study conducted in Hawassa town (Mulatu et al., 2014); Z value is 95% confidence level which is 1.96; and r is the 5% margin error of estimation. Thus n= (1.96)2x 0.135(1-0.135)/ (0.05)2 n= (3.8416) x (0.11087)/ (0.0025) n= 170.36≈ 171 Adding 10% contingency for non-response rate makes the total sample size n = 171+17= 188 This Table displays isolated bacteria among under five children in Hawassa town (Mulatu et al., 2014) and used in this study for calculating the sample size Bacterial pathogens Campylobacter sp Shigella sp Salmonella sp Frequency (%) 20 (12.7%) 11 (7.0%) 4 (2.5%) 12 Sample size (n= z2 x p (1-p)/ r2) 170 100 38 For the specific objective 3: sample size and power for cross sectional study was calculated using Epi-info version 7.1.0.6; taking confidence interval (confidence level or 1-α) = 95%; power (1-β) = 80%; ratio (unexposed to exposed) = 1:1; prevalence of enteropathogenic E. coli causing diarrhoea in unexposed children 10% (unexposed= previous history of diarrhoea), and AOR closest to 1= 2.1 (Jan, 2007). Thus the calculated sample size was 170. Adding 15% contingency for non-response rate, the final sample size was 170+26= 196. The final sample size for third objective was larger than the previous one, so 196 taken. 3.5.2. Sampling Procedure Eligible participants who fulfilled the inclusion criteria were included consecutively until the sample size reached 196. 3.6. Data Collection A face to face interview using structured questionnaires was employed to collect primary data among the participating under five children. The questionnaire was adapted from previous study conducted in prevalence of enteric bacteria among under five children (Mulatu et al., 2014). This questionnaire provides detailed background information, clinical and laboratory data useful for the study. The questionnaires was translated by language experts to Amharic, Afan Oromo and Somale language then back to English by another person to ensure consistency. One clinical nurse and one laboratory technologist were assigned as interviewer and stool sample collector respectively. The principal investigator gave two days training to data collectors about the questionnaire and data collection techniques. Then the questionnaire was pre-tested at Sabian Primary Hospital on 5% of the total sample size which did not included as part of the study group before the start of data collection. Data collection was conducted from February 20 to March 30/2015. After written informed consent obtained from the parents or guardians of the child, background information useful for the study was asked and collected in a form of questionnaire. 3.7. Screening and Identification of Bacterial Agents Causing Diarrhoea 3.7.1. Stool Sample Collection Fresh stool sample and/or rectal swab were collected, placed immediately into screw capped Cary Blair transport media (PARK, Northampton) and transported to Microbiology Laboratory of Dil-Chora Referral Hospital for isolation and identification of enteric bacteria. 13 3.7.2. Inoculation and Incubation The stool sample was inoculated on MacConky agar (PARK, Northampton), Selenite-F-broth (PARK, Northampton), Salmonella and Shigella agar (PARK, Northampton) using streak plate method following the Standard Microbiological techniques and procedures (Cheesbrough, 2006). All culture plates were incubated aerobically for 18 to 24 h at 37oC. Desoxycholate Citrate Agar (PARK, Northampton) was used to subculture from Selenite-F broth and further incubated aerobically for 24h at 37oC. The aseptic condition, purity plate and quality control were maintained throughout the experiment. 3.7.3. Isolation and Identification All positive stool cultures were identified by their physical characteristics such as colony morphology and using Gram stain. Then it was further confirmed by the pattern of biochemical reactions using the standard procedures (Cheesbrough, 2006). Thus Gramnegative rods were identified with the help of a series of biochemical tests such as Kligler Iron slant agar (KIA) (PARK, Northampton), Motility Indole Urea test (MIU) (PARK, Northampton), and Oxidase test (PARK, Northampton) (Cheesbrough, 2006). To obtain the true picture of biochemical tests, pure colonies obtained by sub-culturing on Nutrient broth were used to maximize the process of identification, that is, morphologically identical colonies of the suspected strains were taken from the agar plates and suspended in nutrient broth. Then the suspensions were inoculated to the butt and slant of the biochemical testing media. The inoculated media was incubated aerobically at 37°C and after overnight incubation bacteria was identified following the standard flow chart. 3.7.4. Antibiotic Sensitivity Test The antibiotic susceptibility patterns of the pathogens isolated from the clinical specimen against different antibiotics was done on Mueller Hinton agar (MHA) (PARKS, Northampton). The standard disk diffusion technique of modified KirbyBauer method was used as recommended by Clinical and Laboratory Standard Institute (CLSI, 2014). For disk diffusion testing, antibiotics such as Amoxicillin (30 μg), Ampicillin (10 μg), Ceftriaxone (5 μg), Chloramphenicol (30 μg), Ciprofloxacin (5 μg), Cotrimoxazole (23.75/1.25 μg), Gentamycin (10 μg), and Nalidixic acid (30 μg) were used. Three to five colonies of bacteria from pure culture were picked with an inoculating loop and transferred into a tube containing 5ml nutrient broth and mixed 14 gently until a homogenous suspension formed and incubated at 37oC for 3-5 h until the turbidity of the suspension adjusted to a density of 0.5 McFarland standards, which yield a uniform suspension containing 105-106 cells/ml. Using a sterile non-toxic dry cotton swab, the standardized inoculums were streaked on the entire surface of MuellerHinton agar plate three times, turning the plate at 60º angle between each streaking to ensure even distribution. The inoculums were allowed to dry for 5-15 min. and the selected antibiotic disk were applied onto the plates at a distance of 15 mm away from the edge and 24 mm apart from each other. After incubating the plates at 37oC for overnight, diameters of the zone of bacterial growth inhibition around the disk was measured to the nearest millimeter and the susceptibility or resistance to the agent in each disk was determined and the isolates were classified as sensitive, intermediate or resistant according to the standardized Table provided by the manufacturer (CLSI, 2010). In this study isolated bacteria that was resistant to at least two or more than two groups of antimicrobial agents are regarded as multi-drug resistant (MDR) (Pokharel, 2006). 3.8. Study Variables 3.8.1. Dependent/ Outcome variable Bacterial cause of diarrhoea and drug resistance pattern 3.8.2. Independent/ Explanatory Variables Socio-demographic variables like age and sex of child, place of residence Environmental variables like type of water source, availability of latrine, refuse disposal Behavioral variables like hand washing practice, feeding practices Clinical data like previous history of diarrhoea and treatment, presence of fever, nausea 3.9. Operational Definition of Variables Bacterial diarrhoea: Type of diarrhoea caused by enteric bacteria that invade and colonize host tissue as clinically diagnosed based on symptoms and confirmed by isolation and identification of these bacteria using stool culture. Susceptible (S): The “susceptible” category implies that isolates are inhibited by the usually achievable concentrations of antimicrobial agent when the dosage recommended to treat the site of infection is used. 15 Intermediate (I): The “intermediate” category includes isolates with antimicrobial agent MICs that approach usually attainable blood and tissue levels, and for which response rates may be lower than for susceptible isolates. The intermediate category implies clinical efficacy in body sites where the drugs are physiologically concentrated (eg, quinolones and β-lactams in urine) or when a higher than normal dosage of a drug can be used (eg, β-lactams). Resistant (R): The “resistant” category implies that isolates are not inhibited by the usually achievable concentrations of the agent with normal dosage schedules, and/or that demonstrate MICs or zone diameters that fall in the range where specific microbial resistance mechanisms (eg, β-lactamases) are likely, and clinical efficacy of the agent against the isolate has not been reliably shown in treatment studies. Improved water sources: included household connections, public standpipes, protected dug wells, protected springs. Water sources that are considered as "unimproved" are: unprotected dug wells, unprotected springs. An “Improved” source is one that is likely to provide "safe" water. Proper disposal: is a way of disposal refuses that which included burning, burying in a pit or storing in a container and disposing in designed site, whereas disposing in open fields considered as improper disposal method. 3.10. Data Quality Control The principal investigator gave two days training to data collectors about the questionnaire and data collection techniques. Then the questionnaire was pre-tested on sample populations which did not included in the study. The interviewer was submitted the collected data to the supervisors on daily basis. The principal investigator performed the supervision of data collection procedures on daily basis. Then the collected data was checked for completeness at the end of data collection. During laboratory analysis of stool culture, standard operating procedures were followed. Calibrated equipments were used for measuring reagents and all other materials were checked for proper functionality. Culture media was prepared and sterilized based on the manufactures instruction. Then the sterility of culture media was checked by incubating 3–5% of the batch at 37°C overnight and observed for bacterial growth. Finally, those media which showed any growth were discarded. The American Type Culture Collection (ATCC) strains such as Escherichia coli ATCC 25922, Shigella flexneri ATCC 12021, Salmonella typhimurium ATCC 13311 and Campylobacter jejuni ATCC 16 33560 obtained from Ethiopian Public Health Institute were used as a quality control during stool culture, biochemical test and antimicrobial susceptibility testing. 3.11. Data Analysis The Collected data was checked for completeness, coded, entered and cleaned using Epi-Data version 3.02. Analysis of data was done using SPSS version 16. Descriptive statistics such as frequency, percentage and cross tabulation was used to present the findings. Multivariate analysis was performed using stepwise logistic regression techniques to evaluate whether individual predictors of interest were independently significantly associated with the outcomes of interest. In order to reduce excessive number of variables and resulting instability of the model, only variables with significance P< 0.25 in the bivariate analysis were considered for inclusion in the multivariable analysis. Variables with P < 0.05 in the multivariable analysis were considered significant. 3.12. Ethical Considerations Institutional ethical clearance was first sought from Institutional Health Research Ethics Review Committee, Haramaya University, College of Health and Medical Sciences. Data was collected after written consent from Dire Dawa Regional Health Bureau. During data collection each participant was informed about the aim of the study. The data collectors had discussed the issue of confidentiality and asked for written consent before the start of data collection. Participants were informed that they have full right to refuse or discontinue participating in the research. Based on the result of stool culture and AST, appropriate treatment was given to the participated under five patients. The cost of treatment was covered by the principal investigator. 3.13. Data Dissemination The findings of this research will be submitted to Haramaya University, Dire Dawa health bureau and Dil-Chora Referral Hospital and to other concerning bodies working on prevention and control of childhood diarrhoea. 17 4. RESULTS A total of 196 under five children with diarrhoea were included in this study with a response rate of 100%. Of these participated children 125(63.8%) were from DCRH pediatric OPD and Wards and the rest 71(36.2%) were from pediatric Emergency Triage. Out of the 196 study participants, 105 (53.6%) were males and 91 (46.4%) were females with an overall male to female ratio of 1:0.87. Regarding age of the study participants, 35 (17.9%) were younger than 6 months, 60 (30.6%) were between 6 to 24 months, 49 (25.0%) were between 25 to 36 months, and the rest 28 (14.3%) and 24 (12.2%) were in the age group of 37 to 48 months and 49 to 60 months respectively (Figure- 2). Majority of the participated under five children were urban dwellers 104 (53.1%) while 92 (46.9%) were rural dwellers. 70 60 Male 60 50 40 35 22 21 Total 38 30 20 Female 49 23 28 26 24 16 14 12 11 13 10 0 < 6 months 6-24 months 25-36 months 37-48 months 49-59 months Figure – 2: Age and Sex Distribution of Study Participants 18 4.1. Prevalence of Enteric Bacteria Stool specimens from 196 under five children with diarrhoea were examined using culture methods and a total of 43/196 (21.9%) enteric bacterial pathogens were identified. Of these 43 enteric bacteria, 25 (12.8%) were E. coli, 11 (5.6%) were Shigella sp, and the remaining 7 (3.6%) were Salmonella sp as confirmed by biochemical tests (Table-1). The distribution of these enteric pathogens according to the different age groups, gender and residence is listed in Table-1. Majority, 7(20.0%) children of age less than 6 months, 12(13.2%) female children and 15(16.3%) children from rural residence were positive for E. coli infection. Likewise, 5(8.3%) children in the age group 6-24 months were infected with Shigella sp. Higher positivity was observed among males 8(7.6%) and children from rural residence 9(9.8%). On the other hand, culture positivity of Salmonella sp was higher in the age group 49-59 months, among males and those from urban areas with a percentage of 12.5%, 4.8% and 4.8% respectively. Culture positivity of E. coli showed association with rural residence (p =0.161). Likewise, residence and sex showed significant association with Shigella sp (p = 0.017) and (p =0.190), respectively. But, no association was observed with positivity of Salmonella sp. Table-1:- Distribution of E. coli, Shigella and Salmonella sp with demographic characteristics among under five children with diarrhea at Dil-Chora Referral Hospital from February to March 2015, Dire Dawa, Eastern Ethiopia. Demographic E. coli (n=25) Shigella sp (n=11) Salmonella sp (n=7) variables Pos (%) Neg (%) Pos (%) Neg (%) Pos (%) Neg (%) 7(20.0) 28(80.) 1(2.9) 34(97.1) 2(5.7) 33(94.3) Age in <6 months Sex Residence 6-24 8(13.3) 52(86.7) 5(8.3) 55(91.7) 2(3.3) 58(96.7) 25-36 6(12.2) 43(87.8) 4(8.2) 45(91.8) 0(0.00) 49(100) 37-48 2(7.1) 26(92.9) 0(0.00) 28(100) 0(0.00) 28(100) 49-59 2(8.3) 22(91.7) 1(4.2) 23(95.8) 3(12.5) 21(87.5) Male 13(12.4) 92(87.6) 8(7.6) 97(92.4) 5(4.8) 100(95.2 Female 12(13.2) 79(86.8) 88(96.7) 2(2.2) 89(97.8) Urban 10(9.6) 94(90.4) 3(3.3) p =.190 2(1.9) 102(98.1 5(4.8) 99(95.2) Rural 15(16.3) 77(83.7) p =.161 9(9.8) p = .017 83(90.2) 2(2.2) 90(97.8) p < 0.25 19 Considering clinical findings, 23(15.5%), 20(13.6%), 20(19.4%), and 17(11.4%) of E. coli were detected among children with symptoms of vomiting, abdominal cramps, watery diarrhoea and 1-5 days of diarrhoea duration respectively (Table- 2). However, only children who had vomiting and watery diarrhoea were associated with positivity of E. coli (p = 0.05) and (p = 0.009) respectively. Likewise, Shigella sp was isolated from children who had symptoms of abdominal cramps 10(6.8%), nausea 8(7.2%) and vomiting 9(6.1%). Higher culture positivity was detected from bloody diarrhoea 6(26.1%) than watery 2(1.9%) and mucoid diarrhoea 3(4.3%). In addition, 10(6.7%) of the isolates were detected from children with 1-5 days duration of diarrhoea and only 1(2.2%) isolated from diarrhoea cases with 6-10 days of duration (Table- 2). However, only bloody diarrhoea showed significant association with isolation rate of Shigella sp (p = 0.006). High positivity of Salmonella sp was observed among children who had vomiting 6(4.1%), fever 5(4.1%) and abdominal cramps 5(3.4%). Majority of Salmonella sp was detected from mucoid diarrhoea 5(7.1%) than watery 1(1.0%) and bloody diarrhoea 1(4.3%), while 4(2.7%) isolated from 1-5 days duration of diarrhoea. Except mucoid diarrhoea (p= 0.063), none of the clinical data showed association with positivity of Salmonella sp. Table-2:- Distribution of E. coli, Shigella and Salmonella sp with clinical data among under five children with diarrhea at Dil-Chora Referral Hospital from February to March 2015, Dire Dawa, Eastern Ethiopia. Clinical Data E. coli (n=25) Shigella sp (n=11) Salmonella sp (n=7) Pos (%) Neg (%) Pos (%) Neg (%) Pos (%) Neg (%) Fever Yes 14(11.6) 107(88.4) 7(5.8) 114(94.2) 5(4.1) 116(95.9) No 11(14.7) 64(85.3) 4(5.3) 71(94.7) 2(2.7) 73(97.3) Abdominal Yes 20(13.6) 127(86.4) 10(6.8) 137(93.2) 5(3.4) 142(96.6) cramps No 5(10.2) 44(89.8) 1(2.0) 48(98.0) 2(4.1) 47(95.9) Nausea Yes 14(12.6) 97(87.4) 8(7.2) 103(92.8) 3(2.7) 108(97.3) No 11(12.9) 74(87.1) 3(3.5) 82(96.5) 4(4.7) 81(95.3) Vomiting Yes 23(15.5) 125(84.5) 9(6.1) 139(93.9) 6(4.1) 142(95.9) p = .05 No 2(4.2) 46(95.8) 2(4.2) 46(95.8) 1(2.1) 47(97.9) Type of Watery 20(19.4) 83(80.6) 2(1.9) 101(98.1) 1(1.0) 102(99.0 diarrhoea p = .009 Bloody 2(8.7) 21(91.3) 6(26.1) 17(73.9) 1(4.3) 22(95.7) p = .006 Mucoid 3(4.3) 67(95.7) 3(4.3) 67(95.7) 5(7.1) 65(92.9) p = .063 Diarrhoea 1-5 day 17(11.4) 132(88.6) 10(6.7) 139(93.3) 4(2.7) 145(97.3) duration 6-10 8(17.4) 38(82.6) 1(2.2) 45(97.8) 3(6.5) 43(93.5) p < 0.25 20 Of the twenty five children who drunk from unimproved water source, 6(24.0%) were positive for E. coli compared to those children who drunk from improved water source 19/168 (11.1%) (p= 0.071). Although, the variation was not statistically significant, culture positivity of E. coli was relatively higher among children whose family improperly disposed child’s feces and household refuses with a percentage of 15.4% and 17.30% respectively. Among 25 children who drank from unimproved water sources like river, 4(16.0%) were positive for Shigella sp. High culture positive rate of Shigella sp (11.8%) was observed among children whose parents improperly disposed their household refuses. Similarly, 4/20(20.0%) of children whose parents did not wash their hands after toilet use were infected by Shigella sp relative to 7/178(4.0%) children whose parents wash their hands. However, water source for drinking and hand washing after toilet use showed associated with culture positivity of Shigella sp (p= 0.016) and (p= 0.003) (Table- 3). Higher positivity rate of Salmonella sp was also observed among children who drank from unimproved water sources 2(8.0%), children whose parents had no latrine (4.8%) and improperly disposed household refuses (5.9%). Similarly, 4(20.0%) of Salmonella sp was detected from children whose family did not wash their hands after using toilet. Of the eleven children whose parents did not wash their hand before feeding the child, 1(9.1%) was infected by Salmonella sp compared to 6/185(3.2%) of children whose parents always wash their hand. Likewise, 4(6.1%) of children who had not taken measles vaccination were infected with Salmonella sp. However, only children who drank from unimproved water sources, whose parents did not wash their hand after toilet use and who had not taken measles vaccination were associated with Salmonella sp (p= 0.221), (p = 0.001) and (p = 0.187) as shown in Table- 3 below. 21 Table-3:- Distribution of E. coli, Shigella and Salmonella sp with environmental characteristics among under five children with diarrhea at Dil-Chora Referral Hospital from February to March 2015, Dire Dawa, Eastern Ethiopia. Environmental and E. coli (n=25) Shigella sp (n=11) Salmonella sp (n=7) Behavioral Variables Pos (%) Neg (%) Pos (%) Neg (%) Pos (%) Neg (%) Unimprov Type of water 6(24.0) 19(76.0) 4(16.0) 21(84.0) 2(8.0) 23(92.0) source Improved 19(11.1) 152(88.9) 7(4.1) 164(95.9 5(2.9) 166(97.1 p= .071 p= .016 p= .221 Availability of Yes 18(13.4) 116(86.6) 9(6.7) 125(93.3) 4(3.0) 130(97.0) latrine No 7(11b.3) 55(88.7) 2(3.2) 60(96.8) 3(4.8) 59(95.2) child’s feces improper 6(15.4) 33(84.6) 2(5.1) 37(94.9) 1(2.6) 38(97.4) disposal proper 19(12.1) 138(87.9) 9(5.7) 148(94.3) 6(3.8) 151(96.2) Refuse improper 3(17.7) 14(82.3) 2(11.8) 15(88.2) 1(5.9) 16(94.1) disposal proper 22(12.3) 157(87.7) 9(5.0) 170(95.0) 6(3.3) 173(96.7) Hand washing No 2(10.0) 18(90.0) 4(20.0) 16(80.0) 4(20.0) 16(80.0) after toilet use Yes 23(13.1) 153(86.9) 7(4.0) 169(96.0 3(1.7) 173(98.3 p= .003 p = .001 Hand washing No 2(18.2) 9(81.8) 1(9.1) 10(90.9) 1(9.1) 10(90.9) before feeding Yes 23(12.4) 162(87.6) 10(5.4) 175(94.6) 6(3.2) 179(96.8) History of Yes 23(12.9) 156(87.1) 10(5.6) 169(94.4) 6(3.3) 173(96.7) diarrhoea No 2(11.8) 15(88.2) 1(5.9) 16(94.1) 1(5.9) 16(94.1) vaccinated measles Yes 17(13.0) 114(87.0) 7(5.3) 124(94.7) 3(2.3) 128(97.7 No 8(12.3) 57(87.7) 61(93.8) 4(6.1) p = .187 61(93.9) 4(6.2) p < 0.25 4.2. Antibiotic Susceptibility Pattern of Bacterial Isolate All the isolated bacterial pathogens were subjected to antimicrobial susceptibility tests using disk diffusion method. As it is displayed in Table-4 below, none of the isolates of E. coli, Shigella and Salmonella sp were resistant to Ceftriaxone. But, for other antibiotics different resistance pattern was observed. Accordingly, E. coli showed 56.0% and 52.0% resistance against Amoxicillin and Ampicillin. Lower resistance rate was observed against Ciprofloxacin, Gentamicin and Nalidixic acid (4.0% each) respectively. Likewise Shigella sp showed high resistance against Amoxicillin (100%), Ampicillin (90.9%) and Cotrimoxazole (72.7%) while low resistance rate was observed against Nalidixic acid (18.1%) and Ciprofloxacin (9.1%). The overall rate of resistance of Salmonella sp was higher for Ciprofloxacin (57.2) and Amoxicillin (85.7%) followed by Ampicillin (71.4%). Twenty-eight percent resistance rate were observed against Cotrimoxazole and lower resistance rate was observed against Chloramphenicol (14.3%), Gentamicin (14.3%), and Nalidixic acid (14.3%) (Table- 4). 22 Table- 4: Antimicrobial sensitivity and resistant pattern of bacteria isolate among children under age of five years at Dil-Chora Referral Hospital from February to March 2015, Dire Dawa, Eastern Ethiopia. Antibiotics E.coli No. (%) Shigella sp No. (%) Salmonella sp No. (%) AMP R I S 13(52.0) 7(28.0) 5(20.0) 10(90.9) 1(9.1) 0(0.00) 5(71.4) 2(28.6) 0(0.00) AMC R I S 14(56.0) 6(24.0) 5(20.0) 11(100.0) 0(0.00) 0(0.00) 6(85.7) 0(0.0) 1(14.3) C R I S 6(24.0) 8(32.0) 11(44.2) 5(45.4) 3(27.3) 3(27.3) 1(14.3) 2(28.6) 4(57.1) CRO R I S 0(0.00) 1(4.0) 24(96.0) 0(0.00) 1(9.1) 10(90.9) 0(0.00) 3(42.9) 4(57.1) CIP R I S 1(4.0) 5(20.0) 19(76.0) 1(9.1) 6(54.6) 4(36.3) 4(57.2) 2(28.6) 1(14.3) GM R I S 1(4.0) 5 (20.0) 19(76.0) 3(27.3) 0(0.0) 8(72.3) 1(14.3) 1(14.3) 5(71.4) NA R I S 1(4.0) 5(20.0) 19(76.0) 2(18.1) 3(27.3) 6(54.6) 1 (14.3) 1 (14.3) 5 (71.4) SXT R I S 4(16.0) 8(32.0) 13(52.0) 8(72.7) 2(18.2) 1(9.1) 2(28.6) 2(28.6) 3(42.8) AMP = Ampicillin, CRO = Ceftriaxone, NA = Nalidixic acid, AMC = Amoxicillin, C = Chloramphenicol, GM =Gentamicin, SXT = Cotrimoxazole, CIP = Ciprofloxacin A total of 13, 9 and 6 distinct antibiograms (resistance pattern) were found among all isolates of E. coli, Shigella and Salmonella sp as displayed on Table-3 below. Accordingly, 5(20.0%) of E. coli were resistant to three antimicrobial agents, 10(40.0%) to two and 5(20.0%) showed to one ABCs agents. All Shigella sp were found to be multiple drug resistant, while 5(20.0%) E.coli and 1(14.3%) Salmonella sp showed no resistance against the tested antibiotics. Of the total isolated Shigella sp, 1(9.1%), 4(36.4%) 5(45.5%) and 1(9.1%) were 23 resistant to two, three, four and five drugs respectively. Whereas, 4(52.7%) and 1(14.3%) Salmonella sp showed MDR against three and four drugs. Table-5: Antibiogram of bacterial pathogens isolated from under-five children with diarrhea at Dil-Chora Referral Hospital from February to March 2015, Dire Dawa, Eastern Ethiopia. Number of ABC resistant E. coli No of Resistance isolates Antibiogram No (%) Zero 5(20.0) None - - Salmonella No of Resistan isolates ce No (%) Antibio gram 1(14.3) None One 2(8.0) 1(4.0) 1(4.0) 1(4.0) AMC AMP C SXT - - 1(14.3) - AMC Two 6(24.0) 1(4.0) 1(4.0) 1(4.0) 1(4.0) AMC,AMP AMC,C AMC,SXT AMP,SXT C,SXT 1(9.1) - AMC,AMP - - - Three 3(12.0) AMC,AMP,C 1(9.1) AMC,AMP,C 1(14.3) 1(4.0) AMC,AMP,CIP 2(18.2) AMC,AMP,SXT 2(28.6) 1(4.0) AMC,GN,NA 1(9.1) AMC,C,SXT 1(14.3) AMC,A MP,C AMC,A MP,SXT AMC,A MP,CIP - - 1(9.1) AMC,AMP,GN,NA 1(14.3) AMC,A MP,GN, NA - - 2(18.2) 1(9.1) 1(9.1) AMC,AMP,C,SXT AMC,AMP,C,CIP AMC,AMP,SXT,GN - - Five - - 1(9.1) AMC,AMP,SXT, GN,NA - - TOTAL 25(100.) Four No of isolates No (%) 11(100) 24 Shigella Resistance Antibiogram 7(100.) - 4.3. Possible Associated Factors of Bacterial Diarrhoea Multivariate analyses were carried out to identify the risk factors associated with infection of E. coli, Shigella and Salmonella sp. According to the finding of this study, E. coli was independently associated with vomiting and watery diarrhoea. More specifically, children with symptoms of vomiting had 5.1 times more affected by E. coli than children without vomiting (AOR= 5.1; 95%CI= (1.12, 23.47); p= 0.022). Similarly, the culture positivity of E. coli was 6.9 times higher among children with watery diarrhoea than children with mucoid diarrhoea (AOR= 6.9; 95%CI= (1.92, 24.39); p= 0.003). Shigella sp was also independently associated with residence, bloody diarrhoea and washing hands after toilet use. Thus, the culture positivity of Shigella sp was 5.7 times more likely among children living in rural areas than those from urban areas (AOR= 5.7; 95%CI= (1.05, 31.62); p= .043). Likewise, children with bloody diarrhoea had 11.6 times higher infection with Shigella sp than those children with mucoid diarrhoea (AOR= 11.6; 95%CI= (2.0, 71.60); p= .008). Children whose family wash their hands after toilet use had 90% less likely to be infected with Shigella sp than children whose family did not washed their hands (AOR= 0.1; 95%CI= (.01, .53); p= .008). Salmonella sp was only independently associated with washing hands after toilet use. Therefore, the culture positivity of Salmonella sp was 94% less likely among children whose family wash their hands after toilet use than those children whose family did not wash their hands after toilet use (AOR= 0.06; 95%CI= (.01, .33); p= .008). 25 Table- 6: Multivariable analysis of risk factors for bacterial diarrhoea among under five children at Dil-Chora Referral Hospital from February to March 2015, Dire Dawa. E. coli (n=25) Associated Factors COR(95% CI) AOR(95% CI) pvalu 1 1.8(.77, 4.30) 1 1.1( .40, .95) .889 Urban Rural Pos (%) 10(9.6) 15(16.3) Neg (%) 94(90.4) 77(83.7) No Yes 23(15.5) 2(4.2) 125(84.5) 1 46(95.8) 4.2(1.0, 18.1) 1 5.1(1.12,23.47) .022 Type of diarrhoea Mucoid Watery Bloody 3(4.3) 20(19.4) 2(8.7) 67(95.7) 83(80.6) 21(91.3) 1 6.9(1.92,24.39) 2.9(.445,19.24) .003 .262 Type of water source unimproved improved 6(24.0) 19(11.1) 19(76.0) 1 152(88.9) 0.4(.14, 1.11) Residence Vomiting Sex Residence Male Female Shigella sp (n=11) 8(7.6) 97(92.4) 3(3.3) 88(96.7) 1 5.4(1.53, 18.87) 2.1(.33, 13.60) 1 0.4(0.11-1.6) 1 0.6(.19, 1.78) .357 1 0.2(.03, 1.33) .098 Urban Rural 2(1.9) 9(9.8) 102(98.1 1 83(90.2) 5.5(1.16-26.3) 1 5.7(1.05, 31.6) .043 Type of diarrhoea Mucoid Watery Bloody 3(4.3) 2(1.9) 6(26.1) 67(95.7) 1 101(98.1 0.4(.07, 2.72) 17(73.9) 7.9(1.79,34.79) ) 1 0.6(.08, 4.32) 11.6(2.0, 71.6) .613 .008 Type of water source unimproved improved 4(16.0) 7(4.1) 1 0.2(.06, .83) 1 1.1(.13, 9.14) .599 Hand washing after toilet use No Yes 4(20.0) 7(4.0) 21(84.0) 164(95.9 ) 16(80.0) 169(96.0 ) 1 0.2(.043, .63) 1 0.1((.01, .53) .008 1 0.1(.01, 1.10) 0.6(.06, 6.72) .061 .713 Salmonella sp (n=7) 5(7.1) 65(92.9) 1 1(1.0) 102(99.0 0.13( .01, 1.12) 1(4.3) 22(95.7) 0.6( .07, 5.34) Type of diarrhoea Mucoid Watery Bloody Type of water source unimproved improved 2(8.0) 5(2.9) 23(92.0) 1 166(97.1 0.4(.06, 1.89) 1 0.17(.02, 1.80) .836 Hand washing after toilet No Yes 4(20.0) 3(1.7) 16(80.0) 1 173(98.3 0.07(.01, .337) 1 0.06(.01, .33) .001 Measles vaccination No Yes 4(6.1) 3(2.3) 61(93.9) 1 128(97.7 0.4(.08-1.65) 1 0.5(.07, 3.81) .280 26 5. DISCUSION This study investigated the bacterial cause of diarrhoea, their antibiotic susceptibility pattern and socio-demographic, environmental and behavioral risk factors of bacterial diarrhoea among under five children in Dil-Chora Referral Hospital. The finding of this study revealed that a total of 43 enteric bacterial pathogens identified. The most frequently isolated bacteria in this study was E. coli (25), followed by Shigella sp (11) and Salmonella sp (7). None of the isolated E. coli, Shigella and Salmonella sp showed resistance against Ceftriaxone. E. coli showed 56% and 52% resistance to Amoxicillin and Ampicillin. Similarly, 100%, 91% and 72% of Shigella sp were resistance to Amoxicillin, Ampicillin and Cotrimoxazole respectively. Likewise, Salmonella sp showed resistance to Amoxicillin, Ampicillin and Ciprofloxacin with a rate of 85%, 71% and 57%, respectively. E. coli was independently associated with vomiting and watery diarrhoea, while Shigella sp was independently associated with residence, bloody diarrhoea and washing hands after toilet use. Whereas, Salmonella sp was only independently associated with washing hands after toilet use. The overall prevalence of enteric bacteria isolated in this study (21.9%) is comparable with a similar studies conducted in Hawassa (22.2%) (Mulatu et al., 2014), Jimma (22.3%) (Beyene and Haile-Amlak, 2004), Gondar (20.9%) (World Gastroenterology Organization, 2008) and other country such as Kenya (17.2%) (Willie et al 2012) and Nepal (20.0%) (Jeevan et al., 2009). However, the prevalence is higher compared with previous studies conducted in Butajira (15%) (Mengestu et al., 2014). Globally, diarrhoea caused by enteropathogens remains the second leading cause of death among children under five years of age (USAID, 2010; Ahs et al., 2010) and enteric bacteria are among the major causes of diarrhea (Mitikie et al., 2000). In this study the dominant bacterial pathogens isolated was E. coli (12.8%) which is comparable with previous study conducted in Kenya 11.2% (Willie et al 2012). But, the prevalence is lower compared with the studies done in Nepal (22.8%) (Jeevan et al., 2009) and Tikrit, Iraq (25.9%) (Alrifai et al., 2009). The possible reason for such difference could be different geographical location and study period. Higher prevalence of Shigella sp was reported in Hawassa (20.1%) (Roma et al., 2000), other countries like Botswana (21.0%) (Urio et al., 2001) and Nepal (36.8%) (Jeevan et al., 2009) in contrast to the prevalence of this study (5.6%) which is supported by the studies conducted 27 in Jimma (5.0%) (Beyene et al., 2014), Gondar (5.2%) (Mitikie et al., 2000), Harar (6.7%) (Reda et al., 2011), and other country such as Nepal (4.6%) (Ansari .et al., 2012). The overall prevalence of Salmonella sp in this study was 3.6%. It is lower compared with the findings of other similar studies conducted in Gondar (5.2%) (Mitikie et al., 2000), Jimma (5.2%) (Beyene et al., 2014) and other country such as Nepal (14.03%) (Jeevan et al., 2009). But it is comparable with the finding of studies done in Hawassa (2.5%) (Mulatu et al., 2014) and other developing countries such as Kenya (3.5 %) (Willie et al 2012) and Botswana (3.0%) (Urio et al., 2001). Antimicrobial resistance by enteric pathogen is of major concern because of indiscriminate use of drugs (Temu et al., 2007). In this study low frequency of E. coli resistance was observed relative to Salmonella and Shigella sp. None of the isolated E. coli, Shigella and Salmonella sp showed resistance for Ceftriaxone which is supported by the study conducted in Jimma where all Salmonella and Shigella sp were 100% sensitive for Ceftriaxone (Beyene and Tasew, 2014). High resistance rate of E. coli to Amoxicillin (56.0%) and Ampicillin (52.0%) is somewhat comparable with the report of study done in Madagascar (80%) (Randrianirina et al., 2014). The development of high resistance of Shigella spp against the commonly used antibiotics was witnessed by other investigators in different periods. In Hawassa high rate of resistance of Shigella spp to Ampicillin (93%) and Cotrimoxazole (56%) was reported (Roma et al., 2000), in Gondar high antibiotic resistance was documented against Ampicillin (79.9%) and Cotrimoxazole (73.4%) (Yismaw et al., 2006). High resistance against Amoxicillin (100%) and Ampicillin (100%) was also reported in Harar (Reda et al., 2011). The finding of this study revealed that Shigella sp was 100% resistant to Amoxicillin, 91.0% to Ampicillin and 72.7% to Cotrimoxazole, and lower resistance rate, 9.1% and 18.2%, to Ciprofloxacin and Nalidixic acid was observed. Comparable rate of resistance to Ciprofloxacin (8.3%) was reported in Gondar (Yismaw et al., 2006), 100% resistance to Ampicillin and Amoxicillin reported in Jimma (Beyene and Tasew, 2014). High resistant Shigella isolates to Cotrimoxazole (72.7%) in this study is supported by the study done in Jimma (100%) (Beyene and Tasew, 2014) and Gondar (73.4%) (Yismaw et al., 2006). 28 The finding of this study also revealed that a total of 13, 9 and 6 antibiograms were observed by E. coli, Shigella and Salmonella sp. In addition, all isolated Shigella sp was found to be multi-drug resistant. One (9.1%) Shigella isolate was found to be resistance for 5 antibiotics while 36% and 45% of the isolates were resistant to three and four drugs respectively. A similar finding was seen in previous studies in Ethiopia (Asrat, 2008). MDR Shigella isolates which showed resistance to six antibiotics (Ampicillin, Erythromycin, Cephalothin, Chloramphenicol, Tetracycline and Trimethoprim-sulfamethoxazole) reported in Hawassa (Roma et al., 2000). Likewise, in this study resistance to five drugs (Amoxicillin, Ampicillin, Cotrimoxazole, Gentamicin, and Nalidixic acid) was observed. This may be an alarming issue because majority of drugs commonly prescribed in Ethiopia are now becoming less effective due to the emergence of MDRs Shigella sp mainly due to inappropriate prescribing of these drugs. It is widely recognized that exposure to diarrhoeal pathogens in developing countries is associated with the age of the child, quality and quantity of water, availability of toilet facilities, housing conditions, place of residence, feeding practices, and the general sanitary conditions (personal or domestic hygiene) in the vicinity of the house (Andualem, 2010; WHO/UNICEF, 2009; Wondwossen, 2008). This study also tried to find possible associated socio-demographic, environmental and behavioral factors of bacterial cause of diarrhoea. Although significant association was not observed between age and sex of the child with the isolated enteric bacterial pathogens, overall infection rate was higher among children of age 6-24 months (35%) and among male patients (60.5%). This finding can be supported by the study conducted in Nepal where infection rate was higher in the age group of 6-24 months and boys had higher diarrhoeal cases than girls (78.3%) (Ansari et al., 2012). High frequency of E. coli (80.0%) was detected among children with watery diarrhoea and only 12% and 8% E. coli was isolated from mucoid and bloody diarrhoea respectively. Similarly 92.0% of E. coli was detected among children who had symptoms of vomiting. The culture positivity of E. coli were 5 times more likely among children who had vomiting than children without vomiting (AOR= 5.1; 95%CI= (1.12, 23.47); P= 0.022). Likewise, positivity of E. coli was 6.9 times more likely among children with watery diarrhoea than children with mucoid diarrhoea (AOR= 6.9; 95%CI= (1.92, 24.39); P= 0.003). 29 Majority, 8(7.6%) of Shigella sp were detected among male patients than female 3(3.3%). The distribution of Shigella sp among females and males was not statistically significant (p= .098), which agrees with the study reported in Gondar (Mitikie et al., 2000) and Jimma (Beyene and Haile-Amlak, 2004). Whereas, 9(9.8%) of Shigella positive cases were from children in rural area and this finding is in line with the finding in Yemen (Hassan et al., 2007). Infection with Shigella sp showed statistical significant association with rural residence. Thus, culture positivity of Shigella sp was 5.7 times more likely among children living in rural areas than those from urban areas (AOR= 5.7; 95%CI= (1.05, 31.62); P= .043). This may be due to unprotected water source and presence of domestic animals in almost all rural house hold. In this study, Shigella sp was frequently isolated from children with abdominal cramps (90.9%), vomiting (81.8%), from bloody diarrhoea (90.9%) and with 1-5 days duration of diarrhea (90.9%). This is comparable with the study done in Butajira; abdominal pain (77.5%) and fever (52.5%) (Mengistu et al., 2014). Culture positivity of Shigella sp showed statistically significant association with bloody diarrhoea. Therefore, positivity of Shigella sp was 11.6 times more likely among children with bloody diarrhoea than those children with mucoid diarrhoea (AOR= 11.6; 95%CI= (2.0, 71.60); P= .008). Regarding hand washing practice, among twenty children whose family did not wash their hands after toilet use 4(20.0%) were infected by Shigella sp compared with 7(4.0%) of the total 176 children whose family wash their hands and this showed statistical significant association with Shigella sp. Thus, culture positivity rate of Shigella sp was 90% less likely among children whose family wash their hands after toilet use than children whose family did not wash their hands (AOR= 0.1; 95%CI= (.01, .53); P= .008). The possible reason could be due to fecooral transmission of this bacterium from the parents to the child during feeding and/or handling. Salmonella sp was frequently detected from mucoid diarrhoea (71.4%) than watery (14.3%) and bloody diarrhoea (14.3%). Isolation of Salmonella sp from mucoid diarrhoea is comparable with the study done in Butajira (50.0%) (Mengistu et al., 2014) and Harar (42.8%) (Reda et al., 2011). Similarly, the low isolation rate of Salmonella sp from watery diarrhoea in this study (14.7%) is supported by the study done in Harar where Salmonella sp was not detected from watery diarrhoea (Reda et al., 2011). The finding of this study also 30 revealed that from a total of 20 children whose family did not wash their hands after toilet use, 4(20.0%) were infected with Salmonella sp compared to 3(1.7%) out of 176 children whose family wash their hands, and this was significantly associated with Salmonella sp. Therefore, culture positivity of Salmonella sp was 94% less likely among children whose family wash their hands after toilet use than those children whose family did not wash their hands (AOR= 0.06; 95%CI= (.01, .33); P= .008). The possible reason could be due to fecooral transmission of this bacterium from the parents to the child during feeding and/or handling. However, the other factors showed no significant association with positivity of Salmonella sp. 31 6. STRENGTH AND LIMITATION OF THE STUDY 6.1. Strength All possible associated factors in the bivariate analysis were adjusted in the multivariate logistic regression and the effect of confounding was controlled if its inclusion in the model alters the estimated regression coefficient for the other predictor variable by 15-20% or more. Accuracy of culture results was achieved by using validated and calibrated laboratory instruments, and minimizing inter-observer variation during reading of positive culture plates, biochemical and drug susceptibility tests. 6.2. Limitation of the Study Since the sample size used for this study was somehow small, some of the confidence intervals were wide. There was lack of study on the prevalence and antibiotic profile of E. coli in Ethiopia, so comparison could not be made. Similarly, comparison of associated factors for the isolated bacteria could not be made due to lack of study done in this area. 32 7. CONCLUSION AND RECOMMNDATION 7.1. Conclusion Childhood diarrhea caused by enteric bacteria remains an important health concern in the study community. The overall prevalence of enteric bacterial pathogens identified in this study was found to be high. Diarrhoegenic E. coli was the most predominant bacteria isolated, followed by Shigella and Salmonella sp. Majority of these enteric bacteria frequently isolated among children of age less than 24 months, from male children and those from rural areas. The finding of antibiotic resistance pattern revealed that Ceftriaxone, Gentamicin and Nalidixic acid showed good efficacy against the three bacteria isolates. However, Amoxicillin and Ampicillin found to be less effective antibiotics against isolated E. coli, Shigella and Salmonella sp. Ciprofloxacin is found to be less effective antibiotic for treatment of diarrhoea caused by Salmonella sp. Similarly Cotrimoxazole is less effective antibiotics against Shigellosis. All Shigella sp found to be multiple drug resistance for commonly prescribed drugs in Ethiopia. One Shigella sp was found to be resistant to five antibiotics while five of the isolated Shigella sp was resistant to four drugs. However, only one of the isolated Salmonella sp showed resistance for four drugs. Except Shigella which showed significant association with residence of the child, the other bacteria did not shown association with demographic characteristics. Majority of these enteric bacterial pathogens were detected among children with more than one symptoms of diarrhoea in which vomiting and watery diarrhoea were significantly associated with E. coli, while, bloody diarrhoea was significantly associated with isolation of Shigella sp. Among the environmental and behavioral characteristics, only washing hands after toilet use showed statistical association with Salmonella and Shigella sp, but E. coli was not associated with any of the environmental and behavioral factors. 33 7.2. Recommendations Gentamicin, Chloramphenicol and Cotrimoxazole may be prescribed as an effective antibiotics to treat diarrhoea caused by Salmonella sp Ciprofloxacin and Gentamicin may be prescribed as an effective antibiotics to treat diarrhoea caused by Shigella sp Since multi-drug resistant Shigella sp for commonly used drugs are emerging, antibiotics for treatment of Shigellosis and other enteric bacteria must be used appropriately Children’s families should be encouraged to wash their hands after toilet use because it has protective effect for diarrhoea caused by Shigella and Salmonella sp. Children should always be given improved water Health education should be given to children’s families about proper disposal of child’s feces and household refuses as this will decrease the source of transmission of bacterial diarrhoea Interventions aimed to improve sanitation, hygiene and access to safe drinking water should be strengthen as this will reduce the occurrence of diarrhea caused by enteric bacteria. Further research on isolation of Campylobacter sp among under five children is recommended for other researchers interested in this area. 34 8. REFERENCES Alemu Tamiso, Mezgebu Yitayal, Akilew Awoke .2014. Prevalence and Determinants of Childhood Diarrhoea Among Graduated Households, in Rural Area of Shebedino District, Southern Ethiopia. Science Journal of Public Health; 2(3): 243-251. Alrifai S.B, Alsaadi A, Y.A. Mahmood, A.A. Ali, L.A. Al-Kaisi .2009. Prevalence and Etiology of Nosocomial Diarrhoea in Children Under 5 Years in Tikrit Teaching Hospital, Iraq. Eastern Mediterranean Health Journal; 15(5). Alvin Z, Kerry W, Robert B, Mathuram S, William K, Christophore D, Karren O, Jonathan S .2013. Global Action Plan for Childhood Diarrhoea: Developing Research Priorities. Journal of Global Health; 3(1): 104-06. Andualem Abebe .2010. Assessment of the Impact of Latrine Utilization on Diarrhoeal Diseases in the Rural Community of Hulet Ejju Enessie Woreda, East Gojjam Zone, Amhara Region. Ethiopian Journal of Health Development; 24(3): 110-118. Ansari S, Sherchand JB, Parajuli K, Mishra SK, Dahal RK, Shrestha S, Tandukar S, Pokhrel BM .2012. Bacterial Etiology of Acute Diarrhea in Children Under Five Years of Age. Journal of Nepal Health Resource Council; 10(22):218-23. Asrat Debebe .2008. Shigella and Salmonella Serogroups and Their Antibiotic Susceptibility Patterns in Ethiopia. East Mediterranean Health Journal; 14: 760-767. Beyene Getnet, Haile-Amlak Abebe .2004. Antimicrobial Sensitivity Pattern of Campylobacter Species among Children in Jimma University Specialized Hospital, Southwest Ethiopia. Ethiop Journal of Health Development; 18:185-189. Beyene Getnet, Tasew Haymanot .2014. Prevalence of Intestinal Parasite, Shigella and Salmonella Species Among Diarrheal Children in Jimma Health Center, Jimma Southwest Ethiopia: A Cross Sectional Study. Annals of Clinical Microbiology and Antimicrobials; 13:10. Bhutta ZA, Das JK, Walker N, Rizvi A, Campbell H, Rudan I. 2013. Interventions to Address Deaths from Childhood Pneumonia and Diarrhoea Equitably: What Works and at What Cost? Lancet; 381: 1417-1429. Central Statistics Agency (CSA) of Ethiopia .2007. Central Statistics Agency (CSA) of Ethiopia .2015 (Unpublished). Cheesebrough M .2006. District Laboratory Practice in Tropical Countries. Microbiology Part II, 2nd ed. Cambridge University press, London UK: 105-114. Christa L Fischer Walker, Igor Rudan, Li Liu, Harish Nair, Evropi Theodoratou, Zulfiqar A Bhutta, Katherine L O’Brien, Harry Campbell, Robert E Black. 2013. Global burden of childhood pneumonia and diarrhoea. Lancet; 381: 1405–1416. Available from http://dx.doi.org/10.1016/S0140-6736(13)60222-6. 35 Clinical Laboratory Standard Institute (CLIS) .2014. Performance Standards for Antimicrobial Susceptibility Testing, Twentieth informational supplements, CLSI document M100-S24.Wayne, PA: clinical and laboratory standard Institute. Clinical Laboratory Standard Institute (CLSI) .2010. Performance Standards for Antimicrobial Susceptibility Testing, Twentieth informational supplements, CLSI document M100-S20.Wayne, PA: clinical and laboratory standard Institute. Dutta S, Dutta P, Matsushita S, Bhattacharya SK, Yoshida S .2003. Shigella Dysentriae Serotype 1, Kolkata, India. Emergency Infectious Disease; 9(11):1471-4. ElAstal Z .2005. Bacterial Pathogens and Their Antimicrobial Susceptibility in Gaza Strip, Palestine. Pakistan Journal of Medicine.; 20(4): 365- 370. Elliott EJ .2007. Acute Gastroenteritis in Children. British Medical Journal; 334: 35- 40. Ethiopia Demographic and health survey (EDHS), Central Statistics Authority & ORC Marco. Addis Ababa, Ethiopia and Calverton, Maryland, USA: 2011. Global Burden of Disease (GBD), Ethiopia. 2010. The Global Burden of Disease, Injuries and Risk Factor Study: Institute for Health Metrics and Evaluation (IHME), University of Washington. Available at http//www.healthmetricsandevaluation.org. Accessed on April 2015 Hassan A, Abdualbaki A, Khald A, 2007: Epidemiology, Clinical Features and Antibiotic Susceptibility of Campylobacter Infections in Sanaa, Yemen. Journal of Chinese Clinical Medicine; 2(8):445–463. IOM. 2009. Global Issues in Water, Sanitation, and Health. Washington, DC: The National Academies Press. Available from: http://www.ncbi.nlm.nih.gov/books/NBK28462/. Accessed on April 2015. Jan Egil Afset .2007. Role of Enteropathogenic E.coli in Childhood Diarrhoea in Norway, Norwegian University of Science and Technology (Trondheim): ISBN 978-82-4715823-4 (electronic version) Jeevan B Sherchand, Michiyo Yokoo, Ojaswee Sherchand, Arun R Pant, Osamu Nakogomi. .2009. Burden of Enteropathogens Associated Diarrheal Diseases in Children Hospital, Nepal. Scientific World; 7(7): 71-75. DOI: 10.3126/sw.v7i7.3830 Kelsey JL, Whittemore AS, Evans AS and Thompson WD .1996. Methods of Sampling and Estimation of Sample Size. In: Kelsey J.L., Whittemore A.S., Evans A.S. and Thompson W.D., Eds., Methods in Observational Epidemiology, Oxford University Press, New-York. Mamo Ayele, Hailu Awraris .2014. Assessment of Prevalence and Related Factors of Diarrheal Diseases Among Under-Five Years Children in Debrebirehan Referral Hospital, Debrebirehan Town, North Shoa Zone, Amhara Region, Ethiopia. Open Access Library Journal; 1: e283. http://dx.doi.org/10.4236/oalib.1100283 36 Mengistu Getachew, Geru Mulugeta, Tsehaynesh Lema .2014. Prevalence and Antimicrobial Susceptibility Pattern of Salmonella serovars and Shigella Species. Journal of Microbial Biochem Technology; 52. Merson MH, Black RE, Mills RJ (Eds), .2005. International Public Health, Second Edition. Boston: Jones and Bartlett Publishers. Mitikie G, Kassu A, Genetu A. and Nigussie D., 2000. Campylobacter Enteritis among Children in Dembia District, Northwest Ethiopia. East Africa Medical Journal; 77: 654-657. Mulatu Getamesay, Beyene Getenet, Zeynudin Ahmed .2014. Prevalence of Shigella, Salmonella and Campylobacter Species and Their Susceptibility Patters among Under Five Children with Diarrhea in Hawassa Town, South Ethiopia. Ethiopian Journal of Health Science; 24(2): 101-107. Naghipour M, Nakgomi T, Nakagomi O .2008. Issues With Reducing the Rotavirus Associated Mortality By Vaccination in Developing Countries. Vaccine; 26:3236-41. Randrianirina et al. .2014. Antimicrobial Resistance of Bacterial Enteropathogens Isolated From Stools in Madagascar. BMC Infectious Diseases; 14:104. DOI:10.1186/14712334-14-104. Ravi S, S.P Singh, C.B. Tripathi .2004. Persistent Diarrhoea: Approaches for the Management among Under Five Children. Indian Journal of Preventive Social Medicine; 35(3): 115-119. Reda A, Seyoum B, Jemal Y, Andualem G, Fiseha S, Jean-Michel Vandeweerd J.M .2011. Antibiotic Susceptibility Patterns of Salmonella and Shigella Isolates in Harar, Eastern Ethiopia. Journal of Infectious Disease Immunology; 3:134–139. Accessed on November 10 2014. Roma Belay, worku Sisay, T/Mariam Shimeles, Langeland N .2000. Antimicrobial Susceptibility Pattern of Shigella Isolates in Hawassa. Ethiopian Journal of Health Development; 14: 149-154. Roshani Maharjan, Binod Lekhak, Chandrika Devi Shrestha and Jyotsna Shrestha .2007. Detection of Enteric Bacterial Pathogens (Vibrio Cholerae and Escherichia Coli 0157) in Childhood Diarrhoeal Cases. Scientific World; 5(5). Temu MM, Kaatano GM, Miyaye ND et al., 2007. Antimicrobial Susceptibility of S. flexneri and S. dysenteriae isolated from Stool Specimens of Patients with Bloody Diarrhoea in Mwanza, Tanzania. Tanzania Health Research Bulletin; 9:186-189. UNICEF. 2012. UN Inter-Agency Group for Child Mortality Estimation: Levels and Trends in Child Mortality. New York: United Nations International Children’s Emergency Fund. UNICEF/WHO. 2009. Diarrhoea: Why Children Are Still Dying and What Can Be Done. Urio EM, Collison EK, Gashe BA., Sebunya TK., Mpuchane S .2001. Shigella and Salmonella strains Isolated from Children Under 5 Years in Gaborone, Botswana, and Their Antibiotic Susceptibility Patterns. Tropical Medicine and International Health; 6 (1):55-59. 37 Wanzahun Godana, Bezatu Mengiste .2013. Environmental Factors Associated with Acute Diarrhea among Children Under Five Years of Age in Derashe District, Southern Ethiopia. Science Journal of public Health; 1(3):119-124. WHO .2005. Hospital Care for Children: Guidelines for the Management of Common Illness With Limited Resource. Geneva: World Health Organization. Accessed on September 2014. WHO 2007. Combating Water-Borne Disease at the Household Level: International Network to Promote Household Water Treatment and Safe Storage, World Health Organization, Geneva. Accessed on Sep 2014. WHO/UNICEF. 2013. Ending Preventable Child Deaths from Pneumonia and Diarrhoea by 2025: The Integrated Global Action Plan for Prevention and Control of Pneumonia and Diarrhoea 64(16). ISBN 978 92 4 150523 9. Willie Kipkemboi Sang, Valerie Oundo, David Schnabel .2012. Prevalence and Antibiotic Resistance of Bacterial Pathogens Isolated From Childhood Diarrhoea in Four Provinces of Kenya. Journal of Infectious Developing Countries; 6(7):572-578 Wondwossen Bogale .2008. Stepwise Regression Analysis on Under-Five Diarrhoea Morbidity Prevalence in Nekemte Town, Western Ethiopia: Maternal Care Giving and Hygiene Behavioral Determinants. East African Journal of Public Health; 5(3): 193-198 World Gastroenterology Organization practice guideline: Acute diarrhea. World Gastroenterology Organization, 2008. Available at www.ngc.org World Health Organization (WHO), 2013. Diarrhoeal Disease: Fact Sheet No. 330. Available on http//www.who.int/mediacenter/factsheets/fs330/en. Accessed on September 2015. Yismaw Gebru, Negeri Chala, Kassu Abebe .2006. A Five-Year Antimicrobial Resistance Pattern Observed in Shigella Species Isolated From Stool Samples in Gondar University Hospital, Northwest Ethiopia . Ethiopian Journal of Health Development; 20(3):194-198. 38 9. ANNEXURES Annexure- 1: Participant Information Sheet and Informed Consent Form for Parents or Guardians of Under Five Children Involved In the Study My name is……………………………………. I am working as a data collector for the study being conducted in this community by MOHAMMED MEKONNEN who is studying for his master’s degree at Haramaya University, college of Health and Medical science. I kindly request you to lend me your attention to explain you about the study and being selected as the study participants. The Study Title: Bacterial diarrhoea, their antibiotic susceptibility pattern and associated risk factors among under five children in Dil-Chora Referral Hospital, Dire Dawa, Ethiopia Purpose/aim of the study: The finding of this study can be of a paramount importance for the Regional Health Bureau to plan intervention programs to prevent under five diarrhoea in your community and others; thereby improving public health in general. Moreover, the aim of this study is to write a thesis as a partial requirement for the fulfillment of a Master’s Program in Medical Microbiology for the principal investigator. Procedure and duration: I will be interviewing you using a questionnaire to provide me with pertinent data that is helpful for the study. There are 15 questions to answer where I will fill the questionnaire by interviewing you. Then your child will give stool sample for laboratory investigation. The interview will take about 10 minute, so I kindly request you to spare me this time for the interview. Risk and benefits: The risk of being participating in this study is very minimal, but only taking few minutes from your time. There would not be any direct payment for participating in this study. But the findings from this research may reveal important information for the local health planners. Confidentiality: The information you will provide us will be confidential. There will be no information that will identify you in particular. The findings of the study will be general for the study community and will not reflect any thing particular of individual persons or housing. The questionnaire will be coded to exclude showing names. No reference will be made in oral or written reports that could link participants to the research. 39 Rights: Participation for this study is fully voluntary. You, as the child’s parent or guardian, have the right to declare participate or not in this study. If you decide to participate, you have the right to withdraw from the study at any time and this will not label you for any loss of benefits which you otherwise are entitled you do not have answer any questions that you do not want to answer. Contact Address: If there are any questions or enquiries any time about the study or the procedure, please contact: Mobile Phone: 0913278009 or Email Address: robelmekonnen@gmail.com Contact address of the Institutional Health Research Ethics Review Committee (IHRERC) Office phone: 0256661899 or P.O. Box 235, Harar. Declaration of informed voluntary consent: I have read/ was read to me the participant information sheet. I have clearly understood the propose of the research, the procedures, the risk and benefits issues of confidentiality, the rights of participating and the contact address of any queries. I have been given the opportunity to ask questions for the things that may have been unclear. I, as child’s parent/guardian, was informed that I have the right to withdraw my child from the study at any time or not to answer any questions that I do not want. Therefore, I declare my voluntary consent to participate in this study with my initials (signature) as indicated below). Signatures of participants…………….. Signature of data collector….. N.B: This is signed face to face in the presence of the data collector. Please provide a copy of this signed consent to the participant. 40 S. No 1 Eligibility Questions Responses Does the child have diarrhoea? 2 Does the child took medication for the past 5 days No Yes No Yes Code 0 1 0 1 Structured Questionnaire For Assessing Socio-demographic and Environmental Factors of Bacterial Diarrhoea And Antibiotic Susceptibility Pattern Of The Isolates Among Children Under Five Years Of Age At Dil-Chora Referral Hospital. Date ____/_____/__________ Code Number_______ S. No Socio-demographic characteristics Responses Code 1. Age of the child Less than 6 months 0 6-24 Months 1 25-36 Months 2 37-48Months 3 49-60 Months 4 2. Sex of the child Male 0 Female 1 Urban 0 3. Residence of the child Rural 1 Clinical data (Symptoms of diarrhoea) Presence of fever No 0 4. Yes 1 Presence of abdominal cramps No 0 Yes 1 Presence of nausea No 0 Yes 1 Presence of vomiting No 0 Yes 1 Type of diarrhoea watery diarrhoea 0 5. bloody Diarrhoea 1 mucoid diarrhoea 2 Duration of diarrhoea? 1-5 days 0 6. 6-10 days 1 11-15 days 2 > 16 days 3 Previous history of diarrhoea and previous treatment No 0 7. Yes 1 Environmental and Behavioral Factors 8. What is the type of water source your child use for Household connection drinking? Public standpipes Protected well/ springs Unprotected well/ spring 41 0 1 2 3 9. Do you have a private latrine in your home? 10. Does your child able to use a toilet? 11. If no to Q. 10, How do you dispose of the feces? 12. 13. How do you dispose of your Refuses? Do you wash your hands After using toilet? Before feeding your child? 14. Did your child had previous history of diarrhoea 15. Do your child vaccinated against measles? No Yes No Yes Buried Put in the latrine Thrown away inopen surrounding Other(specify………) Burning Burying in a pit Storing and disposing in designed site Dispose on open fields 0 1 0 1 0 1 Never Sometimes Always Never Sometimes Always Yes No No Yes Do not remember 0 Stool culture result Annexure-2: በጥናቱ ላይ ለሚሳተፉ የህፃኑ እናት ወይም ጠባቂ የተዘጋጀየተሳታፊዎች መረጃ እና የፍቃደኝነት ማረጋገጫ ቅፅ YGý------------------------------------------------------Áp?@$ o™/úŒú K¨| o/UG¿ ¾ŒûsTWüy ½Óþናና 42 ;¡Hና LÁ«Y ¢>þË ½/ú>w” 2 3 0 1 2 3 1 2 0 1 2 1 0 0 1 2 ÆÐQ wGQ ½<Œ¬ú F/FÆ F¢«« >Õናt$ FOÉ WqXoü <• ›½WR/ú ›Î”>/ú$ o±ü;H Õና| ›TY° wXzí ›«Äü<Œú Y>wFOÓú Y>Õናx Î>ä ›«ÄüÃOÐ@°| |«] Îû±þ°|« ›«ÄüWÓú– o|;|ና ›ÓÁc>/ú$ ½Õናx T©Y Æ@ÝR QëR@ <Yõz@ ;äና| ¡ð@ oweGÕ o]z H¡«¿| >;¡Hና »GûFÓú| ;äና| ¬úYÕ ½weGÕ o]z ™HÙ w;®Wü¿|«! FÆ/Œû| FቋቋH p;Q ›ና ተዛማች መንገዶችን ½GûÄYY Õና| Œ¬ú$ የጥናቱ ዓላማ H«H ›«Ÿ« Á; Õና| ½wÃOάú ½Æ;OHOc :ûÃx« >Gሟ?| oü<«H ŒÎT Ы ½Õናx ÕeH »±ü;H o?Á ›«Ã<Œ ÁzFና@$Á;H ®Œ” ½weGÕ o]z ™HÙ w;®Wü¿|« »G¬eH o?Á o™/úŒú W™| o;¡Hና ±úQ¿ |@e …ÐT ½<Œ¬ú« FÆ/Œû| FቋቋH ÁF>»z@$ ow×GQH ½…ÐP« F«Y¨þ°… ¬Á«H H¡«¿}…« >G¬e ÁI¡R@$ Á;H ÃÐI ½weGÕ o]z« >F»?»@ ›ና >FfÔÓT ½Gû¿Y…@ /úŒýz ›«ÃGûëÕT ÁzFና@$ ½Õናቱ eÃH w»w@ና የሚፈጁዉ ጊዜ _ናቱ ጠቃሚ የሆኑ መረጃዎችን በሚጠየቁት ጥያቄ መሰረት ይመልሱልኛል፡፡ ባጠቃላይ 15 ጥያቄዎችን መልስ ይሰጣሉ፡፡ ከዚያም ልጅዎት የሰገራ ናሙና ይሰጣልÝÝ መጠይቁም የሚፈጀዉ ጊዜ 10 ደቂቃ ይሆናል፤ በመሆኑም የህንን ጊዜ ከኔ ጋር እንዲያሳልፉ በትህትና እጠይቅዎታለሁ፡፡ ™ÃÏና ጥቅም በዚህ ጥናት በመሳተፍዎ ያለዉ አደጋ በጣም ጥቂት ነዉ፤ነገር ግን ትንሽ ጊዜ ከርስዎ የወስዳል፡፡ በዚህ ጥናት ሲሳተፉ ሚከፈልዎት ክፍያ አይኖርም፡፡ ነገር ግን የህ ጥናት የጤና እቅድ ለማቀድ ጥሩ መረጃን የሰጣል፡፡ 43 መተማመኛ Y¸s-#N mr© ¸S_‰êE YçÂLÝÝ XRSãN ¥NnT y¸Gl} mr© xYñRMÝÝ k_ናቱም የሚገኘዉ ዉጤት አጠዋላይ የህብረተሰቡ እንጂ የአንድን ግለሰብ ወይም ቤት አያመላክትም፡፡ መጠይቁም ላይ ስም ወደ ሌላ የተረጎማል፡፡ምንም ዓይነት ማጣቀሻ ተሳታፊዉን ከጥናቱ ጋር የሚያያይዝ በቃላትም ይሁን በፅሁፍ አይኖርም፡፡ Fq}… o±ü; Õና| FXwð oFú>ú ðcÖŒ| ?Á ½wFWOw Œ¬ú$ o±ü; Õና| >FXwð ¬ÁH ?>FXwð Fq| ™>°|$ >FXwð ¬YŒ¬ú »<«! oë>Îú| Îû±þ »Õናቱ ማቃረጥ ይችላሉ፡ ይህም የማይፈልጉትን ጥያቄ ባለመመለስዎ የሚያስቀርብዎት ጥቅም የለም፡፡ አድራሻ ስለ ጥናቱ ወይም ሂደት በማንኛዉም ጊዜ ጥያቄ ካለዎት፤ በዚህ አድራሻ ያግኙን፡ ሞባይል ቁጥር፡ 0913278009 ወይም ኢሜይል አድራሻ፡ robelmekonnen@gmail.com IHRERC አድራሻ፡ የቢሮ ስልክ ቁጥር፡ 0256661899 ወይም ፖ.ሳ.ቁ. 235 ሀረር የፍቃደኝነት ማረጋገጫ የተሳታፊዎች መረጃ አንብቤዋለሁ/ተነቦልኛል፡፡ የጥናቱንም ዓላማ፤ሂደቱን፤አደጋና ጥቅሙን፤መተማመኛዉን፤ የመሳተፍ መብት እና አድራሻ በግልፅ ተረድቼዋለሁ፡፡የልተረዳሁትንም ነገር እንድጠይቅ ምቹ ሁኔታ ተመቻችቶልኛል፡፡ከጥናቱም ልጄን በፈለኩት ሰዓት ለማቃረጥ ወይም የማልፈልገዉን ጥያቄ ላለመመለስ መብት እንዳለኝ ተነግሮኛል፡፡ስለዚህም በዚህ ጥናት በፈቃደኝነት መሳተፌን ክዚህ በታች ባለዉ ፊርማዬ እገልፃለሁ፡፡ ½wXzí¬ú íTG---------------------------------------------------------------- 44 ½FOÉ WqXoü¬ú íTG- ተ. ቁ ለጥናቱ ለመሳተፍ መመዘኛ ጥያቄዎች ምላሽ 1 ህፃኑ የተቅማጥ በሽታ አለዉ 2 ህፃኑ ባለፉት 5 ቀናት የተቅማጥ በሽታ መድሃኒት ወስዳል የለም አዎ 1አልወሰደም አዎ 1 መለያ 0 1 0 1 Æ@ÝR QëR@ <Yõz@ ;äና| ¡ð@ oweGÕ o]z H¡«¿| >;¡Hና »GûFÓú| ;äና| ¬úYÕ ®Œ” ½weGÕ o]z ™HÙ w;®Wü¿|« ›ና FÆ/Œû| FቋቋH p;Q ½GûÄYY FÓÁe ቀን ____/_____/__________ መለያ ቁጥር ………………… ተ. ቁ Y> GDoR­ /úŒýz ½Gû¿F?¡x Õ¿d°… ምላሽ 1. የህጻኑ/ና ዕድሜ ስንት ነዉ? ከ6 ወር በታች 0 ከ6 እስከ 24 ወር 1 ከ25 እስከ 36 ወር 2 ከ37 እስከ 45 ወር 3 ከ49 እስከ 60 ወር 4 ወንድ 0 ሴት 1 ከተማ 0 ገጠር 1 ህፃኑ ትኩሳት አለዉ የለም አለ 0 1 ህፃኑ የሆድ ህመም አለዉ የለም አለ 0 1 ህፃኑ የማቅለሽለሽ ስሜት አለዉ የለም አለ 0 1 ህፃኑ ያስታዉከዋል የለም አለ 0 1 2. 3. የህፃኑ/ና ፆታ ? የህፃኑ መኖሪያ ቦታ የት ነዉ ? መለያ የበሽታዉ ምልክቶች 4. 45 5. ፈሳሽ ዉሃ የተቅማጡ አይነት? 0 ደም የቀላቀለ 1 ንፍጥ የቀላቀለ 2 1-5 ቀን 6-10 ቀን 11-15 ቀን > 16 ቀን 6. ተቅማጡ ምን ያህል ጊዜ ቆዬ? 7. ህፃኑ ከዚህ በፊት ተቅማጥ ታሞ መድሃኒት የወሰደ መሆኑን የሚያሳይ የለም የጤና መረጃ አዎ 0 1 2 3 0 1 የአካባቢ እና ግላዊ የበሽታዉ መንስዔዎችን ዳሰሳ 8. ለህፃኑ የመጠጥ ዉሃ ከየት ታገኛላችሁ? ከባነባ 0 ከቦኖ ዉሃ 1 ከተከለለ ጉድጉዋድ/ምንጭ 2 ካልተከለለ ጉድጉዋድ/ምንጭ 3 9. በቤታችሁ የግል ሽንት ቤት አለ ? የለም አዎ 0 1 10. ልጅዎ ሽንት ቤት መጠቀም ይችላል ? አይችልም አዎ 0 1 11. ለጥያቄ ቁጥር 10 መልስዎ አይችልም ከሆነ ሰገራዉን እንዴት ነዉ በመቅበር የሚያስወግዱት ? 12. የቤት ዉስጥ ቆሻሻን የሚያስወግዱት እንዴት ነዉ 0 ሽንት ቤት መክተት 1 ግላጭ መሬት ላይ መጣል 2 ሌላ መንገድ ካለዎት ይጥቀሱ 3 በማቃጠል 0 ጉድጉዋድ ዉስጥ በመቅበር 1 ዕቃ ዉስጥ በማጠራቀም በተዘጋጀ የቆሻሻ ስፍራ መጣል 2 13. 3 በጭራሽ 0 አንዳንዴ 1 ሁል ጊዜ 2 በጭራሽ 0 አንዳንዴ 1 ሁል ጊዜ 2 እጅዎትን መቼ መቼ ይታጠባሉ ከሽንት ቤት መልስ ህፃኑን ከመመገብዎ በፊት 14. ግላጭ ሜዳ ላይ በመጣል ልጅዎ ከዚህ በፊት በተቅማጥ በሽታ ታሞ ያዉቃል 46 አዎ አያዉቅም 1 2 15. ልጅዎ ከዚህ በፊት የኩፍኝ ክትባት ተከትቦ ያዉቃል አያዉቅም አዎ አላስታዉስም 0 1 2 Annexure-3: Odeefannon hirmattotaa Qo’annoo waa’ee jermilee garaa kaasaa fidaniifi qorichaa waliin walbaruu isaanii daa’immani ilaala Maqaan kiyya ------------------------- jedhama. Yeroo ammaa kana yunivarsitii Haroomayaatti digrii lammataabarachaa kanjiru Mohammed Mekonnen wajjiiin odeeffannoo funaanaatiin jira. Qo’annoo kanaaf waan filatamtaniif waa’ee qo’annichaa yeroon isinii himu akka na dhageeffattan kabajaaniin inin gaafadha. Mata Duree Qo’annoo Qo’annoo waa’ee jermilee garaa kaasaa fidaniifi qorichaa waliin walbaruu isaanii hospitaala Dilchoratii kutaa daa’immani ilaala. Kaayyoo Qo’annoo Qorannoon kun digrii lammataa ittiin ebbifamuuf tahullee fayidaan isaa kana qofaa miti. Kuniis garaa kaasaaf jermilee sababa tahan beekuuf fi qorichaa wajjiin walbaruu isaanii ni qo’ata. Akkasumaas sababa rakkoo beekuuf ni yaala. Kuniis dhukkuba garaa kaasaa ittisuufi ta’achuuf ni gargaara. Akkataa qo’nnnoofi yeroo fudhatu Adeeffanno qo’annoof barbaachisu gaafille qo’annoof dhibaate gaafachuun deebisaanaaf kennan walumaagalatii gaafilee deebisaa kennitu. dai’ma sagaraas ni kaniitaa. Yeroo hanga daqiiqaa 10 fudhata. Kanaafuu yeroo kana na wajjiin akka dabarsitan kabajaan isin gaafanna. Midhaafi fayidaa qoranno 47 Qorannoo kanarrati hirmaachuuf midhaan isin irra gahu baay’ee xiqqaadha. Haaata’uu malee, yeroo keessan xiqqo fudhachuu ni danda’a. qorannoo kanarrattii yeroo hirmaattan kafalttin isiniif kafalamu hin jiru. Qorannoon kun karoora fayyaarratti karroorsuuf odeeffannoo ni kenna. Amantummaa Odeeffannoon kennitan icitiin isaakan eeggameedha. Waa’ee kee odeeffannon ibsu hin jiru. Bu’aan qorannoorraa argamu ummata waligalaatiifi malee kan nama tokko hin ilaallatu. Gaafilee yeroo gaafatamtan maqaan keessan lakkoofsa iciti ni kennamaaf. Mirga Qo’annoo kanarratti hirmaachuun fedhii keessan qofaan ta’a. hirmachuufiis hirmachuu dhiisuufiis mirga qabdan. Hirmachuuf kan murteessitan taanaan, yeroo barbaaddanitti adda muruuf mirga qabdan. Gaafilee hin barbaanne deebissu dhabuuf bu’aan sirraa hafu hin jiru. Teessoo Waa’ee qorannoorratti gaafii qabaannon yeroo barbaaddanitti teessoon kanaan nu argachu dandeessu. Lekkoysa bilbilaa: 0913278009; email: robelmekonnen@gmail.com IHRERC teesso፡ lakkoysa bilbilaa: 0256661899 ykn lekkoysaa postaa 235 Harar Ibsa hayyamammaa Odeefannon hirmattotaa dubbiseera/ naaf dubbifameera. Kaayyoo, adeemsa, midhaafi bu’aa, amantummaa, mirga hirmachuufi teesso qo’annoo ifatti hubadheera. Waaniin hin hubatin akkaan gaafadhuuf haalli mijjaawaan naaf uumameera. Qo’annoorraa yeroo berbaadetti hafuufi akkasumaas gaafileen hin barbaanne deebisuu dhirsuuf mirga akkaan qabu naaf himameera. Kanaafuu qo’annoo kanarratti hirmachuu kiyya mallattoo gaditti ibsa meeniin mirkaneessa. Mallatto hirmaataa…………………….. mallatto walitti qabaa odeeffannoo………. 48 Qo’annoo waa’ee jermilee garaa kaasaa fidaniifi qorichaa waliin walbaruu isaanii hospitaala Dilchoratii kutaa daa’immani ilaala guyya ____/_____/__________ lakkoyissaa ………………… 1. Ummri dai’ma jia 6 gadi jia 6 hanga 24 jia 25 hanga 36 jia 37 hanga 45 jia 46 hanga 60 1 2 3 4 5 2. Daii’ma Dhira Dhala 1 2 3. Bakka daii’mni itti jiratu maglaa badiya 1 2 Daii’ma leyadaa niqbaa? eyee mittii 1 2 Daii’ma garraa niimura? eyee mittii 1 2 Daii’ma niqoqiifaata? eyee mittii 1 2 Daii’ma haqissa niqaba? eyee mittii 1 2 Daii’ma allabati niqaba? eyee mittii 1 2 5. Sagarran mal fakaata? 6. Allabatii guyya meqqa ture? Akka bishaani diiggaa niqaba furri niqaba guyya 1 hangaa 5 ture guyya 6 hangaa 10 1 2 3 1 2 4. 49 guyya 11 hangaa 15 guyya 16 7. Sagarran mal fakaata? 8. Bishaan dhugaattiiff tahuu essa irraa fayadamtan? 9. Akka bishaani diiggaa niqaba furri niqaba Bishaan Bonba irraa Bishaan egamee maddaa irraa Bishaan haro irraa 3 4 1 2 3 1 2 3 11. niijirraa 1 hinjiirru 2 Daii’manii mana fincanii nifayadamaa niijirraa 1 hinjiirru 2 Yoo deebiin gaffii 10ffaa mittii ta’e sagarran daii’ma Laffa qottani kesati darbu 1 eyssatii harattan? Karaa irraatti darbu 2 Manaa fincannitti darbu 3 Kanbirra yooqabattan…………. 4 12. Qoshasha akkamitti harraattan 13. harkaa keessan yoom dhiqatqn? 10. Mana fincannii dhunfa niiqaabdanii ? gubudhan 1 laffatti awaludhan 2 bakka qoshashattiidarbudhan 3 karaa irrattii darbudhan 4 harkaa keessan mana fincanii boddaa niidhiqattani? daii’maffa nyatta bilcheysun dura 14. daiima amma dura allbattiin qabe niibeka? 15. amma duraa kittabatti shiifte fudhatte nibekaa 50 Mittii Guyyaa tokko tokko hooguu niidhiqana Mittii Guyyaa tokko tokko hooguu niidhiqana eyee mittii 1 eyee mittii 1 2 2 3 1 2 3 1 2 Annexure-4: Waxaan akhriyey warqada warbixinta Xaaladaha cayayaanka ili ma argtayda iyo kudul noolayaasha ku keena shuubanka iyo ka hortaga u nuglaanshahooda caruurta 5 sano ka yare e dhakhtarka Magacaygu waa______________waxaan ahay xog ururriye ururrinaya daraasaad kusaabsan bulshda, dhigtana barasha heerka labaad( master degree) ee jaamacada haramaya qaybta caafimadka iyo sayniska magacayguna yahay MOHAMMED MEKONNEN waxaan si naxariisle kaaga codsanyaa in aad isiiso dareenkaaka aad ku sharaxaso daraasadan isla markana aad kaga qayb qaadato. Ciwaanka daraasada Xaaladaha cayayaanka ili ma argtayda iyo kudul noolayaasha ku keena shuubanka iyo ka hortaga u nuglaanshahooda caruurta 5 sano ka yare e dhakhtarka DILCHORA, Dire Dawa,Ethiopia. Ujeedada daraasada Natiijada daraasadani waxay muhiiim u noqonaysaa xafiiska caafimaadka ee gobolka si ay u qorsheeyaan waxqabadka iyo barnaamijyada lagaga hor tagayo shubanka caruurta ka yar 5 sano ee bulshada. Ujeedada daraasadani waa in la qoro cilm I baadhis kaaso qayb ka ah barnaamijka wax barashada heerka labaad (master) eek u saabsan dawaynta cayayaanka yaryar si baadhitaan dheeraada loogu sameeyo. Habka iyo mudada Waxaan kula yeelan doonaa waraysi anoo isticmaalaya qaab su aaleed qoraal ah si aad iisiiso xog ku saabsan daraasadayda. Waxa jira suaalo aad ka jawaabaysid kaasi oon kaaga qaadi doono hab waraysi 15 waraysigu. Ilmuhu Saxarahagu waa isee. wuxuu qaadan dooona 10 daqiiqo sidaa daraaded waxaan kaa codsanayaaa inaad ii hurto wakhtigaaaga muhiiimka ah. Khatarta iyo faa,idada daraasadan: Khatarta kaqayb qaadashada daraasadani waa mid aad u kooban laakiin waxay qaadan doontaa daqiiqado yar oo kamida wakhtigaaga.. Majiri doonto kharash toosa oo lagaga qayb qaadanayo daraasadan. laakiin natiijada cilmibaadhistani waxay war bixin muhiima siinaysaa gadhwadeenada dajiya qorshayaasha caafimadka ee deegaanka.. Sirta daraasada War bixinta aad nasiisaa waxay noqondoontaa mid qarsoon. Majiri doonto war bixin si gaara u muujinasa ka qaybgalkaaga.natiijada daraasadani waxay u noqon doontaa bulshada mid guud oo aan cid gaara khusayn. Hadaba qaab su aaleedkan waxaa lagu calaamadin doonaa 51 inaan la muujin wax magaca mana jiri doonto wax tixraaca oo ku saabsan warbixinta qoraalka ama waraysiga ka qayb galaha Xuquuqda Ka Qayb Galaha Ka qaybgalka daraasadani waa mid muta dawac nimo ah. Waxaad xaq uu leedahy in aad cadayso kaqayb galkaaga daraasadan iyo in kale. Hadii aad go aansato in aad ka qayb qaadato waxaad xaq uleedahay inaad isaga tagto daraadan wakhtiga aad doonto taasina calaamad u ma aha inay kaa luminayso faa idooyinka kuu gaarka ah. Ciwaanka La Igala Soo Xidhiidhayo Hadii ay jirto wax su aala ah oo ku saabsan habka daraasadan fadlan igala soo xidhiidh Taleefanka gacanta: 0913278009 ama email address: robelmekonnen@gmail.com Waxa kale oo la iga helaa numberka xafiiska cilmi baadhista iyo anshaxa Lanbarka xafiisaka:0256661899 ama P,O BOX 235,HARAR Cadaynta Mutadawacnimadayda. Waxaan akhriyey warqada warbixinta ka qayb qaataha.waxaan si cad u fahmay u jeedada daraasada,habka,khatarta iyo faaidada ,cadaymaha kalsoonaanta,xaqa ka qayb qaataha iyo halka la igala soo xidhiidhayo wixii loo baahdo. waxaan ku siiyey fursad aad igu weydiiso su,aalaha aan kuu cadayn.waxaan kuu sheegay inaan xaq u leeyahay inaan iska daayo daraasadan wakhtiga aan doono ama aanad ka jawaabin su,aalaha aanan doonaynin. Sidaa Ilmuhu daraadeed waxaan ku cadaynayaa mutadawacnimadayda khusaysa daraasadan sexeexayga gaarka ah sida hoos ku qoran. Sexeexa ka qaybqaataha_________________taarikhda____________________ Xog ururiyah:magaca____________________sexeexa________taarikhda________ 52 Xaaladaha cayayaanka ili ma argtayda iyo kudul noolayaasha ku keena shuubanka iyo ka hortaga u nuglaanshahooda caruurta 5 sano ka yare e dhakhtarka DILCHORA, Dire Dawa, Ethiopia. malinta ____/_____/__________ nambbarka ………………… 1. Daada ilmuhu waimisa 6 bilod wax kahosiyo baa 6 bilod ilaa iyo 24 bilod 25 bilod ilaa iyo 36 bilod 37 bilod ilaa iyo 45Bilod 46 bilod ilaa iyo 60 bilod 2. Ilmuhu wa maxa? Niin Naag 1 2 3. Xalked kunoshahay Wadan Badiye 1 2 1 2 3 4 5 Xumad 4. Xumad ? Mugira Magiro 1 2 Calool xanun? Mugira Magiro 1 Laganyo? 2 Mugira Magiro 2 matag Mugira Magiro 1 2 5. Shubanka midabkisa? 6. Shubanka waa ilaiyo imisa isho? 7. Saxarahagu wasede? 8. Xalkid ka istic mashin biyaha cuntada aad ? Maa biyo baa 1 Dhig mukugira 2 1-5 mallimod 1 6-10 mallimod 2 11-15 mallimod 3 >16 inkabadan baa 4 Maseda biyaba 1 Ghig mixu leyahay 2 Maseda senka 3 Banbada 1 Maa biyaha shicbkad istimaghin 2 Ciilka aan dadhahalin 3 Ciilka ladaholay 4 9. Suuli garmadledinin? 10. Ilmahagu suligu muistimalikara Haa Maay Haa Makarayo 53 1 1 2 1 2 11. Hadu Karen inu istimalin xalkebu kuxura 12. Qushashka xalkid baad kuturtin? 13. Goormad midata gocmahago? Aseed Suligad kudhax rida Maa dulkad kuturtin Ama diriqkalay 15. 2 3 4 Maad gubtiin Maa godbaad ku astiin Maa alab’baad ku uririsin Maa dhulkaad kuturtiin Markad ka sohaxdid suliga 14. 1 Mamido Marmar Marwalba Ilmaha intanad cunsenikur Mamido Marmar Marwalba Imika ka hor ilmahagu xanunka shaban ka mu ku Haa dhacay? Mayaa Imika ka hor ilmahagu mu ku dhacay jodeco? Haa Mayaa 1 2 3 4 1 2 3 1 2 3 1 2 1 Annexure- 5:- Informed Consent Form for Dil Chora Hospital Chief Executive Officer My name is MOHAMMED MEKONNEN who is studying for master’s degree at Haramaya University, college of Health and Medical science. I kindly request you to lend me your attention to explain you about the study being conducted in this Hospital. The Study Title: 54 2 Bacterial diarrhoea, their antibiotic susceptibility pattern and associated risk factors among under five children in Dil-Chora Referral Hospital, Dire Dawa, Ethiopia Purpose/aim of the study: The finding of this study can be of a paramount importance for the Regional Health Bureau to plan intervention programs to prevent under five diarrhoea in the community and others; thereby improving public health in general. Moreover, the aim of this study is to write a thesis as a partial requirement for the fulfillment of a Master’s Program in Medical Microbiology for the principal investigator. Procedure and duration: I will be interviewing parents or guardians of the children using a questionnaire to provide me with pertinent data that is helpful for the study. There are 15 questions to answer where I will fill the questionnaire by interviewing them. Then stool sample will be collected from the participating under five children. The interview will take about 10 minute. Risk and benefits: The risk of being participating in this study is very minimal, but only taking few minutes from parents or guardians of the participating under five children. There would not be any direct payment for participating in this study. But the findings from this research may reveal important information for the local health planners. Confidentiality: The information they will provide us will be confidential. There will be no information that will identify the participating under five children in particular. The findings of the study will be general for the study community and will not reflect any thing particular of individual persons or housing. The questionnaire will be coded to exclude showing their names. No reference will be made in oral or written reports that could link participants to the research. Rights: Participation for this study is fully voluntary. Parents or guardians of the participating under five children have the right to declare participate or not in this study. If parents or guardians decide to participate, they have the right to withdraw their children from the study at any time and this will not label them for any loss of benefits which they otherwise are entitled they do not have answer any questions that they do not want to answer. 55 Contact Address: If there are any questions or enquiries any time about the study or the procedure, please contact: Mobile Phone: 0913278009 or Email Address: robelmekonnen@gmail.com Contact address of the Institutional Health Research Ethics Review Committee (IHRERC) Office phone: 0256661899 or P.O. Box 235, Harar. Declaration of informed voluntary consent: I, chief executive officer of Dil-Chora Hospital, have read the informed consent form. I have clearly understood the propose of the research, the procedures, the risk and benefits issues of confidentiality, the rights and the contact address of any queries. I was informed that I have the right to stop the study at any time if there are any misconduct. Therefore, I declare my voluntary consent of this study to be conducted in this hospital with my initials (signature) as indicated below). Signatures of chief executive officer…………….. N.B: This is signed face to face in the presence of the data collector. Please provide a copy of this signed consent to the participant. Annexure -6: Laboratory Data Laboratory Data (Stool culture request form) Haramaya University, School Of Graduate Studies, College Of Health And Medical Sciences, Department Of Medical Laboratory Science Bacterial Diarrhoea, Antibiotic Susceptibility Pattern Of Isolates And Associated Risk Factors Among 56 Under Five Children At Dil-Chora Referral Hospital, Dire Dawa, Eastern Ethiopia. LABORATORY REQUEST FORM Label number: ________ Time of sample collection ____:_____ Age _______ Sex Male Female Date of sample collection ____/_____/_____ Laboratory Results Stool culture Name of lab personnel BIOCHEMICAL PATHOGENS Bacterial isolates signature FLOW-CHARTS KIA TSI FOR IDENTIFICATION Biochemical tests Motility Indole 57 OF Urea ENTERIC Oxidase S. typhi S. paratyphi Shigella spp E. coli V. cholerae K/A K/A K/A A/A,G K/A K/A K/A K/A A/A,G A/A + + + + +/+ - - + ENTERIC PATHOGENS: Salmonella and Shigella spp., V. cholerae, E. coli and others Inoculums: Growth or direct colony suspension, equivalent to a 0.5 McFarland standard. Use Mueller Hinton agar. Incubate at 35 ± 2oC ambient air for 16 – 18 hours. Drug Amoxicillin/clav ulanate Ampicillin Ceftriaxone Chloramphenicol Ciprofloxacin Trimethoprim/Su lfamethoxazole Gentamicin Nalidixic-acid Tetracycline Conc. (μg) 20/10 Sensitive ≥ 18 Intermediate 14-17 Resistant ≤ 13 10 5 30 5 1.25/23.75 ≥ 17 14-16 ≤ 13 ≥ 18 ≥ 21 ≥ 16 13-17 16-20 11-15 ≤ 12 ≤ 15 ≤ 14 10 30 30 ≥ 15 13-14 ≤ 12 ≥ 15 12-14 ≤ 11 Annexure-7: Curriculum Vitae 1. PERSONAL INFORMATION NAME: -------------------------- MOHAMMED MEKONNEN Sex: - ----------------------------- Male 58 Date of Birth: ------------------- March 14/1983 GC Marital Status: ------------------ Married Nationality: ----------------------Ethiopian Health status; --------------------Excellent Residence: ------------------------Dire Dawa Tel:-------------------------------- 0913278009 Email: robelmekonnen@gmail.com 2. LANGUAGE PROFICIENCY English________________ Excellent in listening, speaking, writing and reading. Amharic________________ Excellent in listening, speaking, writing and reading. Oromipha ____________ Very Good in listening, speaking, writing and reading. 3. EDUCATIONAL BACKGROUND Nifas Silk High School---------------EGSEC Fasiledes Preparatory School--------ESLCE Jimma University ---------------------BSC in Medical Laboratory Technology 4. WORK EXPERIENCE From 1999-2000 EC at SNNPRS in Mizan Teferi health center as head of laboratory advisor From 2000-2001 EC at Dire Dawa Bilal Hospital(private hospital) From 2001-2007 EC at Dire Dawa Dil Chora referral Hospital and different health center 5. INTEREST Reading medical books and Journals Working with society. Reading philosophy books 6. REFERENCES Dr, Gashaw Seid working at ICAP-CU program officer at Dire Dawa o TEL :- 0911757592 Mr. Endris Mekonnen working at JEPHIGO int. o TEL;- 0911480080 59